Other extrapyramidal and movement disorders in other diseases

G6_XTRAPYROTH

Stiff-Person syndrome: Stiff-man syndrome (SMS) is a rare neurological disorder comprising fluctuating trunk and limb stiffness, painful muscle spasms, task-specific phobia, an exaggerated startle response, and ankylosing deformities such as fixed lumbar hyperlordosis.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G25, G26* Hospital discharge: ICD-9 — 333 Hospital discharge: excluded ICD-9 — 3330\|3336 Cause of death: ICD-10 — G25, G26* Cause of death: ICD-9 — 333 Cause of death: excluded ICD-9 — 3330\|3336 2 out of 7 registries used, show all original rules.	7600
4. Check minimum number of events None	7600
5. Include endpoints G6_RLS	10829
6. Filter based on genotype QC (FinnGen only)	10510

Control definitions (FinnGen only)

Control exclude: G6_XTRAPYR

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF10

NAME	G6_XTRAPYROTH
CONTROL_EXCLUDE	G6_XTRAPYR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_RLS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G25\|G26
HD_ICD_9	333
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	3330\|3336
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G25\|G26
COD_ICD_9	333
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	3330\|3336
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other extrapyramidal and movement disorders in other diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	57572	32364	24873
Only index persons	52038	29908	22130
Unadjusted period prevalence (%)
Whole population	0.82	0.93	0.69
Only index persons	0.99	1.10	0.84
Median age at first event (years)
Whole population	66.04	66.60	65.27
Only index persons	65.34	65.93	64.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10510	6308	4202
Unadjusted period prevalence (%)	2.11	2.24	1.93
Median age at first event (years)	64.22	62.42	66.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10829: Matched controls
108290

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N06AX21

ATC

duloxetine; oral

2.9

322.2

1788

6945

N04BC05

ATC

pramipexole; oral

24.0

307.7

4592

3219

N06AX11

ATC

mirtazapine; oral

2.5

307.7

4732

25536

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

+∞

307.7

1006

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

358.3

307.7

1458

N05AH04

ATC

quetiapine; oral

3.2

307.7

2724

10329

N03AX16

ATC

[U] pregabalin

2.5

307.7

3406

16900

C07AA05

ATC

propranolol; systemic

4.6

307.7

4119

12698

N03AA03

ATC

primidone; oral

112.4

307.7

231

N02BF01

ATC

gabapentin; oral

3.8

307.7

1580

4678

N04BD01

ATC

selegiline; oral

88.7

307.7

418

N04BC09

ATC

rotigotine; transdermal

125.3

307.7

209

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

58.8

307.7

202

N03AE01

ATC

clonazepam; systemic

7.3

307.7

1634

2574

N03AX12

ATC

[U] gabapentin; oral

3.5

307.7

2997

10808

N87

ICPC

Parkinsonism

72.6

307.7

499

N04

ICPC

Restless legs

28.5

307.7

329

119

G25.2

ICD-10 Finland

Other specified forms of tremor

88.4

307.7

586

N04BC04

ATC

ropinirole; oral

89.3

307.7

535

N05BA04

ATC

oxazepam; oral

2.3

307.7

3551

18732

R25.1

ICD-10 Finland

Tremor, unspecified

19.5

307.7

1564

930

G24.3

ICD-10 Finland

Spasmodic torticollis

29.2

307.7

240

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

307.7

5708

G25.0

ICD-10 Finland

Essential tremor

112.2

307.7

3309

423

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

57.4

307.7

1661

341

G25.1

ICD-10 Finland

Drug-induced tremor

234.5

307.7

252

G20

ICD-10 Finland

Parkinson disease

290.0

307.7

1211

F51.0

ICD-10 Finland

Nonorganic insomnia

2.6

304.7

2161

9492

N06AX16

ATC

venlafaxine; oral

2.7

303.0

1969

8282

G47.3

ICD-10 Finland

Sleep apnoea

2.3

282.9

2927

15166

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.0

280.9

1359

4871

R53

ICD-10 Finland

Malaise and fatigue

2.2

263.9

3112

16926

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

47.3

263.8

154

N04AA02

ATC

biperiden; systemic

7.5

263.1

383

527

N06AB04

ATC

citalopram; systemic

2.2

250.4

2740

14421

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

242.8

1646

7012

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

609.2

241.9

239

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

237.4

1263

4751

G24.9

ICD-10 Finland

Dystonia, unspecified

119.3

231.9

118

N03AG01

ATC

valproic acid; systemic, rectal

3.3

227.3

905

2876

G25.3

ICD-10 Finland

Myoclonus

329.7

225.8

228

N05CF01

ATC

zopiclone; oral

2.0

223.8

4008

25075

M79.6

ICD-10 Finland

Pain in limb

1.9

220.7

4950

33306

N05AH03

ATC

olanzapine; systemic

3.4

220.4

867

2733

N06AB10

ATC

escitalopram; oral

2.2

218.6

2430

12780

AA1AD

NOMESCO Finland

CT of head and brain

2.0

213.1

3438

20685

M54.5

ICD-10 Finland

Low back pain

1.9

212.9

4202

27038

N02BF02

ATC

pregabalin; oral

3.1

203.2

906

3076

R42

ICD-10 Finland

Dizziness and giddiness

2.0

191.0

2910

17055

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.9

190.3

959

3486

N03AX09

ATC

lamotrigine; oral

3.5

189.5

677

2003

N03AX11

ATC

topiramate; oral

4.9

186.8

420

881

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

183.0

918

3326

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

178.7

1847

9363

N04BD02

ATC

rasagiline; oral

450.1

178.5

178

N05BA01

ATC

diazepam; systemic, rectal

2.2

175.6

1668

8170

N05AN01

ATC

lithium; oral

4.9

174.3

396

838

N06AB06

ATC

sertraline; oral

2.4

169.3

1375

6298

R06.0

ICD-10 Finland

Dyspnoea

1.8

168.5

3237

20312

N05AX12

ATC

aripiprazole; systemic

3.9

168.2

519

1389

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.4

166.6

1336

6082

L03

ICPC

Low back symptom/complaint

1.8

164.1

3205

20183

N02AX02

ATC

tramadol; systemic, rectal

1.7

162.4

4888

34865

N06AX26

ATC

vortioxetine; oral

2.7

162.2

916

3528

N06AX12

ATC

bupropion; oral

2.9

161.7

836

3073

N05CF02

ATC

zolpidem; oral

2.0

156.3

2083

11549

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.5

154.7

386

881

P06

ICPC

Sleep disturbance

2.2

152.1

1419

6871

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

151.9

1332

6287

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

151.3

1056

4507

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.3

150.9

610

1946

G04BD12

ATC

mirabegron; oral

2.1

145.9

1539

7815

M03BX02

ATC

tizanidine; oral

1.7

142.9

6563

51702

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

142.4

804

3090

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

142.2

3087

19900

N06AB03

ATC

fluoxetine; oral

2.1

140.3

1489

7570

N05AA02

ATC

levomepromazine; systemic

3.3

139.6

548

1716

L17

ICPC

Foot/toe symptom/complaint

1.7

139.4

3308

21849

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.0

139.4

303

617

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

138.9

4006

27896

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.2

138.1

290

573

193

Kela drug reimbursment

Rasagiline

+∞

137.8

132

R03AC02

ATC

salbutamol; inhalant

1.7

137.3

5893

45409

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

1319.2

133.6

130

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

132.7

935

3999

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

132.3

3291

21956

L28

ICPC

Limited function/disability (L)

1.9

131.7

2151

12681

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

131.7

4553

33100

N02BE01

ATC

paracetamol; systemic, rectal

2.2

131.6

9696

86404

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

131.4

664

2405

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

35.9

131.2

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

131.0

2025

11727

A02BC02

ATC

pantoprazole; systemic

1.7

131.0

7453

61360

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

128.9

1012

4541

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.2

127.9

528

1704

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

127.8

1016

4583

R51.80

ICD-10 Finland

Headache

2.0

127.3

1728

9576

M25.5

ICD-10 Finland

Pain in joint

1.7

126.8

3462

23625

N05BA12

ATC

alprazolam; oral

2.2

124.8

1227

6039

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

122.9

3201

21537

N05CD07

ATC

temazepam; oral

2.0

122.3

1418

7426

N06AA09

ATC

amitriptyline; systemic

2.1

121.7

1224

6075

A02BC05

ATC

esomeprazole; systemic

1.6

120.8

4486

32974

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

118.7

3288

22439

A04

ICPC

Weakness/tiredness general

1.9

118.4

1713

9677

G44.2

ICD-10 Finland

Tension-type headache

2.0

117.0

1554

8527

N08

ICPC

Abnormal involuntary movements

17.4

116.1

M48.0

ICD-10 Finland

Spinal stenosis

2.0

114.1

1511

8277

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.0

113.4

330

845

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

26.2

113.0

P76

ICPC

Depressive disorder

2.5

112.6

729

2990

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

112.6

1219

6213

M79.1

ICD-10 Finland

Myalgia

1.9

112.3

1611

9061

P03

ICPC

Feeling depressed

2.2

111.5

1012

4815

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

110.8

2529

16343

N06AX22

ATC

agomelatine; oral

4.1

109.3

310

779

N06AX03

ATC

mianserin; oral

2.7

108.8

628

2434

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

108.4

2123

13131

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.0

108.2

508

1764

L01

ICPC

Neck symptom/complaint

1.9

107.8

1733

10099

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

186.9

106.6

111

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

105.3

657

2645

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.8

103.3

556

2078

N05AX08

ATC

risperidone; systemic

2.2

103.3

950

4539

N06AB05

ATC

paroxetine; oral

2.5

101.5

707

2997

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

101.2

4711

36009

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.4

101.2

254

582

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

100.9

4999

38723

P01

ICPC

Feeling anxious/nervous/tense

2.1

100.7

1118

5739

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.4

99.6

376

1147

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.3

98.8

201

386

M79.7

ICD-10 Finland

Fibromyalgia

2.9

98.7

469

1639

SPAT1240

SPAT

Therapeutic discussion

2.1

98.7

1073

5464

N06AX05

ATC

trazodone; oral

3.5

98.6

355

1051

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

12.6

98.2

R52.9

ICD-10 Finland

Pain, unspecified

2.0

97.6

1142

5972

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

247.2

95.8

G24.8

ICD-10 Finland

Other dystonia

168.2

95.3

100

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.9

94.7

209

431

A02BC03

ATC

lansoprazole; oral

1.6

93.2

3111

21956

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

93.0

2369

15653

F32

ICD-10 Finland

Depressive episode

2.5

92.9

596

2430

TAB00

NOMESCO Finland

Lumbar puncture

2.6

91.4

534

2080

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

91.3

2305

15184

R06.5

ICD-10 Finland

Mouth breathing

2.1

91.3

973

4913

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

90.7

7248

61539

A28

ICPC

Limited function/disability NOS

1.7

89.5

1938

12252

N05AF03

ATC

chlorprothixene; systemic

3.4

89.0

321

951

A01

ICPC

Pain general/multiple sites

2.0

87.3

1060

5606

R01AD09

ATC

mometasone; nasal

1.5

86.6

4545

35250

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

86.3

2800

19567

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.7

86.2

201

434

N29

ICPC

Neurological sympt/complt other

3.7

86.0

279

771

S18

ICPC

Laceration/cut

1.5

85.4

4819

37890

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

84.4

1537

9243

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

84.2

792

3808

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

83.9

1500

8971

P20

ICPC

Memory disturbance

1.8

83.4

1568

9512

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

83.4

1879

11982

F32.1

ICD-10 Finland

Moderate depressive episode

2.4

83.3

589

2510

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

83.3

1298

7446

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

82.8

1908

12238

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

214.2

82.4

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.6

82.0

278

791

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

81.9

1351

7884

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

12.8

81.9

R02

ICPC

Shortness of breath/dyspnoea

1.8

81.0

1453

8691

F34.1

ICD-10 Finland

Dysthymia

2.8

81.0

420

1538

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

80.9

1068

5804

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

80.6

2283

15411

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

80.4

606

2656

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.6

80.3

466

1807

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

+∞

80.3

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

80.1

2641

18471

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

79.2

4586

36059

XA800

NOMESCO Finland

Neuropsychological investigation

2.6

79.1

471

1850

A02BC01

ATC

omeprazole; systemic

1.5

79.0

2902

20779

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.1

78.4

328

1065

N17

ICPC

Vertigo/dizziness

1.8

78.2

1373

8155

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

78.1

901

4672

P29

ICPC

Psychological sympt/compl other

2.2

76.8

666

3096

R13

ICD-10 Finland

Dysphagia

2.1

76.3

794

3965

M01AH05

ATC

etoricoxib; oral

1.5

75.9

6217

52054

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

75.8

1162

6620

J01DB01

ATC

cefalexin; oral

1.6

75.5

8630

77249

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

75.5

3236

23898

N06AG02

ATC

moclobemide; oral

2.4

74.9

515

2166

R35

ICD-10 Finland

Polyuria

2.1

74.9

763

3779

SPAT1301

SPAT

No procedures

1.5

74.7

3302

24525

A06AD11

ATC

lactulose; oral

1.7

74.6

1582

9900

R25.2

ICD-10 Finland

Cramp and spasm

3.1

74.3

316

1036

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

74.0

1761

11357

SPAT1216

SPAT

Assessment of functional ability

1.7

73.7

1721

11043

N06AA06

ATC

trimipramine; systemic

3.1

73.7

320

1062

K02.1

ICD-10 Finland

Caries of dentine

1.4

73.5

5723

47336

M01AE02

ATC

naproxen; oral, rectal

1.4

72.7

5634

46517

R03DC03

ATC

montelukast; oral

1.7

72.3

1686

10811

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.2

72.0

295

946

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

71.6

726

3588

C07AB07

ATC

bisoprolol; oral

1.4

71.6

5122

41632

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

71.4

4161

32552

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

71.2

2827

20499

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.3

71.0

278

867

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

71.0

429

1697

N04BX02

ATC

entacapone; oral

+∞

70.9

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.3

70.5

141

267

H02AB06

ATC

prednisolone; systemic

1.4

70.4

4917

39741

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

70.3

4488

35681

J01AA02

ATC

doxycycline; systemic

1.5

70.0

8057

71420

3AX01, ,

NOMESCO Finland

14.0

69.8

F31

ICD-10 Finland

Bipolar affective disorder

4.6

69.7

166

365

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.1

69.6

291

944

N30.0

ICD-10 Finland

Acute cystitis

1.6

69.5

1733

11290

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

69.3

357

1302

J45

ICD-10 Finland

Asthma

1.8

69.2

1092

6270

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

68.9

1061

6045

M01AB05

ATC

diclofenac; systemic, rectal

1.4

68.7

6704

57454

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

68.7

842

4454

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.2

68.3

277

883

N05BE01

ATC

buspirone; oral

2.8

67.6

346

1257

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

67.1

1766

11650

SPAT1053

SPAT

Memory test

1.6

67.1

1614

10414

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

66.9

325

1148

M03BX01

ATC

baclofen; systemic

3.4

66.7

239

705

ZY010

NOMESCO Finland

Hospital outpatient

2.3

66.6

516

2286

N06AA12

ATC

doxepin; systemic

2.2

66.6

600

2831

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

66.5

6499

55538

J02AC01

ATC

fluconazole; systemic

1.4

66.5

3881

30256

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.5

66.4

235

688

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

66.2

7123

61910

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

65.9

3743

29021

R52.2

ICD-10 Finland

Other chronic pain

2.5

65.6

434

1792

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.9

65.5

191

490

P99

ICPC

Psychological disorders other

2.9

65.0

310

1084

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

64.8

1384

8653

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

+∞

64.6

SPAT1260

SPAT

Consultation of another employee

1.6

64.6

1854

12474

SPAT1263

SPAT

Sampling

1.4

64.5

4259

33900

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

9.3

64.4

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.7

64.4

208

573

N05AB03

ATC

perphenazine; systemic, rectal

2.6

64.0

383

1507

R60.0

ICD-10 Finland

Localized oedema

1.7

63.7

1337

8317

3338X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Fragments of torsion dystonia

+∞

63.6

R05

ICD-10 Finland

Cough

1.5

62.9

2184

15325

SFA10

NOMESCO Finland

One-surface restoration

1.4

62.9

5337

44306

H03AA01

ATC

levothyroxine sodium; systemic

1.5

62.6

2421

17379

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.4

62.6

223

656

SPAT1254

SPAT

Administration of medicine

1.6

62.5

1548

10044

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

62.5

1616

10598

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

62.4

606

2943

Z71.8

ICD-10 Finland

Other specified counselling

1.5

62.2

2999

22489

Z01.2

ICD-10 Finland

Dental examination

1.4

62.2

4365

35045

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.1

62.2

170

416

SPAT1229

SPAT

Assessment of need for aid

1.9

62.1

868

4790

L02

ICPC

Back symptom/complaint

1.8

62.0

996

5741

XKD00

NOMESCO Finland

Uroflowmetry

1.6

61.9

1567

10220

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

61.9

1887

12860

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

61.8

1059

6221

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

7.5

61.8

118

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

3.0

61.6

274

922

AA400

NOMESCO Finland

Electroconvulsive therapy

5.5

61.4

119

219

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

61.1

742

3907

E0000UV, ,

ATC

1.4

61.1

4150

33101

M54

ICD-10 Finland

Dorsalgia

1.7

60.2

1207

7408

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

60.0

3052

23087

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

59.6

1980

13740

L12

ICPC

Hand/finger symptom/complaint

1.6

59.6

1605

10618

N06DA03

ATC

rivastigmine; oral, transdermal

2.3

59.5

459

2029

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

59.4

1178

7208

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

59.3

1068

6362

R55

ICD-10 Finland

Syncope and collapse

1.7

59.3

1168

7134

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

59.1

4538

36894

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

59.1

381

1554

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

58.6

1175

7209

SFA20

NOMESCO Finland

Two-surface restoration

1.4

58.6

5616

47348

UJF32

NOMESCO Finland

Coloscopy

1.5

58.2

2712

20156

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

57.5

525

2487

F61.0

ICD-10 Finland

Mixed personality disorders

3.5

56.8

195

560

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.2

56.7

230

733

L15

ICPC

Knee symptom/complaint

1.5

56.7

2402

17512

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

56.5

1304

8297

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

56.3

5382

45232

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.4

55.8

202

600

Z2445

NOMESCO Finland

Psychologist

2.4

55.8

378

1577

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

55.5

1577

10549

R06AE07

ATC

cetirizine; oral

1.4

55.4

4284

34746

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

55.4

2240

16166

U02

ICPC

Urinary frequency/urgency

1.6

55.3

1467

9657

R03BA02

ATC

budesonide; inhalant

1.5

55.1

1756

12055

J01CA04

ATC

amoxicillin; systemic

1.4

55.0

8263

74734

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.6

55.0

183

515

R03BA08

ATC

ciclesonide; inhalant

1.8

54.9

888

5122

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

54.8

3889

31080

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

54.8

536

2609

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

54.5

600

3051

UKC02

NOMESCO Finland

Cystoscopy

1.6

54.3

1619

10947

K59.0

ICD-10 Finland

Constipation

2.0

54.3

612

3138

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

54.2

1120

6920

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.0

54.2

237

790

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.7

54.1

301

1142

R05

ICPC

Cough

1.5

54.1

2372

17386

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.7

53.6

294

1108

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

53.6

513

2476

R07.3

ICD-10 Finland

Other chest pain

1.7

53.4

1039

6314

J01EA01

ATC

trimethoprim; systemic

1.4

53.4

2640

19784

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

53.3

1329

8611

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

53.3

1327

8595

R25.0

ICD-10 Finland

Abnormal head movements

21.1

53.2

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

53.1

1423

9381

L08

ICPC

Shoulder symptom/complaint

1.5

52.3

2164

15664

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.8

52.3

264

953

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

52.0

4151

33734

K30

ICD-10 Finland

Functional dyspepsia

1.7

52.0

1120

6992

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.5

51.8

332

1350

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

51.8

666

3571

R01AD08

ATC

fluticasone; nasal

1.4

51.6

2713

20537

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.7

51.6

279

1044

R11

ICD-10 Finland

Nausea and vomiting

1.8

51.2

875

5124

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

51.1

1797

12577

R03BB04

ATC

tiotropium bromide; inhalant

1.7

51.1

1033

6340

M01AC06

ATC

meloxicam; systemic, rectal

1.4

50.9

3591

28578

R00.2

ICD-10 Finland

Palpitations

1.8

50.7

780

4428

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

50.7

2761

21025

D01

ICPC

Abdominal pain/cramps general

1.7

50.6

1126

7086

P74

ICPC

Anxiety disorder/anxiety state

2.3

50.6

388

1711

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

50.6

422

1928

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

50.5

2452

18285

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

50.3

319

1291

N06BA04

ATC

methylphenidate; oral

2.8

50.2

260

951

U07

ICPC

Urine symptom/complaint other

1.8

50.1

782

4458

S06.0

ICD-10 Finland

Concussion

1.7

50.0

1040

6432

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

49.9

860

5049

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

49.8

443

2077

L13

ICPC

Hip symptom/complaint

1.5

49.7

1868

13249

P01AB01

ATC

metronidazole; oral, rectal

1.4

49.7

3884

31396

R49.02

ICD-10 Finland

Spasmodic dysphonia

10.9

49.4

R01AD58

ATC

fluticasone, combinations; nasal

1.5

49.1

2179

15962

S29

ICPC

Skin symptom/complaint other

1.5

49.1

1905

13593

A98

ICPC

Health maint/preventive medicine

1.9

48.9

10239

97662

N99

ICPC

Neurological disease other

3.6

48.7

164

465

SPAT1310

SPAT

Counselling related to known health issue

1.4

48.6

3114

24348

A02BA02

ATC

ranitidine; systemic

1.5

48.5

1928

13823

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

48.4

5001

42144

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.6

48.4

281

1090

Z3226

NOMESCO Finland

Physiotherapist

1.5

48.3

1794

12687

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

48.1

873

5199

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

4.7

47.9

111

239

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.4

47.8

172

N04BB01

ATC

amantadine; oral

3.3

47.6

179

545

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

47.6

613

3287

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

47.4

836

4937

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

47.3

2198

16228

A11

ICPC

Chest pain NOS

1.7

47.2

853

5072

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

47.2

592

3146

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

47.2

578

3048

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.6

47.1

113

250

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.8

47.1

145

387

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

47.1

603

3227

N01

ICPC

Headache

1.7

46.8

959

5903

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

46.7

407

1892

R01AD12

ATC

fluticasone furoate; nasal

1.4

46.5

2819

21805

R03BA05

ATC

fluticasone; inhalant

1.5

46.4

1734

12267

R4110, ,

SPAT

1.7

46.3

874

5260

R51

ICD-10 Finland

Headache

2.0

46.3

529

2724

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.7

46.1

147

402

N03AF01

ATC

carbamazepine; oral, rectal

2.0

45.9

505

2564

A97

ICPC

No disease

1.5

45.9

1732

12272

C03CA01

ATC

furosemide; systemic

1.4

45.7

3041

23875

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

45.6

729

4184

M54.1

ICD-10 Finland

Radiculopathy

2.1

45.2

419

1997

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

45.0

336

1465

SPAT1153

SPAT

Removal of sutures

1.4

44.9

3158

25001

3331A

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Essential and other specified forms of tremor

+∞

44.8

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

44.8

412

1957

SPAT1234

SPAT

Support of social functional capacity

1.9

44.7

547

2882

F51

ICD-10 Finland

Nonorganic sleep disorders

2.2

44.7

383

1768

WX290

NOMESCO Finland

Other blockage of nerve

1.3

44.6

4145

34235

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

44.6

2430

18434

R96

ICPC

Asthma

1.7

44.5

967

6039

R27.0

ICD-10 Finland

Ataxia, unspecified

6.2

44.5

124

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

5.8

44.4

141

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.8

44.3

229

837

IHZ05, ,

SPAT

2.5

44.3

285

1162

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

5.6

44.2

152

L14

ICPC

Leg/thigh symptom/complaint

1.7

44.0

806

4810

G25.5

ICD-10 Finland

Other chorea

+∞

43.8

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

43.5

2810

21918

M54.2

ICD-10 Finland

Cervicalgia

1.8

43.4

751

4409

L86

ICPC

Back syndrome with radiating pain

1.9

43.1

616

3414

N07BB01

ATC

disulfiram; oral

2.2

43.1

381

1782

G04BD08

ATC

solifenacin; oral

1.8

43.1

693

3983

N05AH02

ATC

clozapine; systemic

3.2

43.0

169

529

G04CA02

ATC

tamsulosin; oral

1.4

42.8

2115

15755

SPAT1243

SPAT

Psychiatric/psychological examination

2.7

42.8

238

904

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

42.4

356

1630

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

42.3

1883

13756

H81

ICPC

Excessive ear wax

1.5

42.3

1708

12249

SPAT1312

SPAT

General health counselling

1.4

42.3

3028

23993

R03BA01

ATC

beclometasone; inhalant

1.5

42.0

1361

9332

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

41.8

625

3512

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

41.8

1915

14063

Z3231

NOMESCO Finland

Registered nurse

1.4

41.6

2632

20435

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.9

41.6

124

324

N05AE05

ATC

lurasidone; oral

7.5

41.5

D07AC01

ATC

betamethasone; topical

1.3

41.3

3458

28040

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

41.2

246

968

A02BC04

ATC

rabeprazole; oral

1.7

41.2

842

5174

R74

ICPC

Upper respiratory infection acute

1.4

41.1

2707

21144

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.3

40.7

330

1490

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.0

40.7

181

610

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

40.6

683

3976

D11

ICPC

Diarrhoea

1.6

40.5

1051

6850

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

40.4

986

6333

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

40.3

4058

33761

R06AX27

ATC

desloratadine; oral

1.4

40.2

2538

19679

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

40.1

680

3968

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

39.9

3403

27630

SFA30

NOMESCO Finland

Three-surface restoration

1.3

39.8

3934

32623

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

39.8

527

2850

R1250

NOMESCO Finland

Evaluation of functional capability

2.6

39.8

233

908

D82

ICPC

Teeth/gum disease

1.3

39.8

3314

26813

M01AH01

ATC

celecoxib; oral

1.4

39.7

1743

12687

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

39.6

3579

29302

R03AC03

ATC

terbutaline; inhalant

1.5

39.4

1314

9053

R5110, ,

SPAT

1.8

39.4

673

3935

M02AA07

ATC

piroxicam; topical

1.3

39.3

3518

28754

R12

ICD-10 Finland

Heartburn

1.7

39.1

766

4651

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

39.1

1293

8894

N04BX04

ATC

opicapone; oral

389.0

39.1

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

38.9

1354

9411

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

38.9

576

3227

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

38.8

504

2709

N28

ICPC

Limited function/disability (N)

2.8

38.8

193

692

N05AD01

ATC

haloperidol; systemic

2.3

38.8

299

1322

IBA03

NOMESCO Finland

Psychotherapy evaluation

4.3

38.7

231

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

38.6

1337

9282

E61.1

ICD-10 Finland

Iron deficiency

2.7

38.6

207

772

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

5.4

38.5

139

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

38.4

444

2294

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

4.4

38.4

220

D12

ICPC

Constipation

2.1

38.3

373

1811

Z01.7

ICD-10 Finland

Laboratory examination

1.5

38.3

1368

9558

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

38.3

1885

13998

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

38.2

1079

7167

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

37.8

1533

10979

R4110

NOMESCO Finland

Physiotherapy

1.4

37.6

2643

20808

N05AA01

ATC

chlorpromazine; systemic, rectal

3.4

37.5

137

410

3339X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Other and unspecified extrapyramidal diseases and abnormal movement disorders

+∞

37.5

R21

ICPC

Throat symptom/complaint

1.4

37.5

1737

12752

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

37.5

333

1560

F40.1

ICD-10 Finland

Social phobias

2.7

37.5

209

795

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.2

37.3

316

1453

N04BC06

ATC

cabergoline; oral

5.7

37.2

122

J01DA01

ATC

[U] cefalexin

1.3

37.2

6011

53083

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.1

37.2

152

488

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

37.0

434

2253

A99

ICPC

Disease/condition unspecnature/site

1.6

37.0

893

5716

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

36.9

683

4082

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

36.9

1213

8328

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

36.8

1932

14498

G04CA01

ATC

alfuzosin; oral

1.5

36.7

1094

7351

L29

ICPC

Musculoskeletal sympt/complt other

1.6

36.6

835

5272

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

36.5

664

3950

M03AX01

ATC

botulinum toxin; parenteral

3.5

36.5

127

369

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

36.2

291

1310

Z00.0

ICD-10 Finland

General medical examination

1.4

36.1

1805

13423

L16

ICPC

Ankle symptom/complaint

1.5

36.1

1061

7108

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

35.9

502

2761

N06AX17

ATC

milnacipran; oral

3.4

35.9

130

387

J01MA02

ATC

ciprofloxacin; systemic

1.3

35.9

3761

31313

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

35.9

400

2041

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

5.1

35.6

149

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

35.6

1258

8760

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

35.6

1886

14162

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

35.6

2178

16754

R4120

NOMESCO Finland

Occupational therapy

1.7

35.6

620

3644

A29

ICPC

General symptom/complaint other

1.5

35.5

1205

8323

G47.8

ICD-10 Finland

Other sleep disorders

3.2

35.5

143

455

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

35.3

1281

8968

N06AB08

ATC

fluvoxamine; oral

2.3

35.3

268

1177

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

35.1

3436

28321

Z2446

NOMESCO Finland

Social worker

1.8

35.1

584

3386

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

5.0

35.1

151

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

34.9

834

5323

WX002

NOMESCO Finland

Sedation and analgesia

1.4

34.7

1877

14137

M54.3

ICD-10 Finland

Sciatica

1.8

34.7

583

3390

K07.60

ICD-10 Finland

Snapping jaw

1.9

34.6

449

2413

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

34.5

402

2083

A03FA02

ATC

cisapride; oral, rectal

1.7

34.5

726

4490

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

34.4

603

3548

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

34.4

2443

19217

D06

ICPC

Abdominal pain localized other

1.6

34.4

812

5167

IGY02, ,

SPAT

3.5

34.3

118

340

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

34.3

1485

10755

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

7.1

34.2

L60.0

ICD-10 Finland

Ingrowing nail

1.9

34.2

442

2371

J01FA06

ATC

roxithromycin; oral

1.3

34.2

3760

31457

C10AA05

ATC

atorvastatin; oral

1.3

34.2

4080

34501

M02AA10

ATC

ketoprofen; topical

1.4

34.1

1520

11063

A08

ICPC

Swelling

1.8

34.1

518

2924

Z2221

NOMESCO Finland

Medical doctor

1.3

34.0

2554

20253

KMAK, ,

NOMESCO Finland

1.3

34.0

4699

40478

J01CA08

ATC

pivmecillinam; oral

1.3

33.8

3841

32255

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

33.7

762

4796

N06BA07

ATC

modafinil; oral

6.3

33.7

G21.8

ICD-10 Finland

Other secondary parkinsonism

120.4

33.7

H02

ICPC

Hearing complaint

1.5

33.6

1352

9652

J20

ICD-10 Finland

Acute bronchitis

1.6

33.6

940

6226

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

33.3

203

807

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

33.2

763

4822

K07

ICPC

Swollen ankles/oedema

1.8

33.2

476

2639

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

33.2

1701

12686

A05

ICPC

Feeling ill

1.8

32.9

499

2814

SPAT1058

SPAT

PEF monitoring instruction

1.6

32.9

788

5030

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

170.5

32.7

M01AX17

ATC

nimesulide; oral

1.3

32.6

2290

17961

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

32.3

290

1365

WX723

NOMESCO Finland

CPAP therapy

2.0

32.3

367

1886

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

31.9

394

2083

U05

ICPC

Urination problems other

1.8

31.8

493

2800

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

31.7

535

3115

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

31.7

1344

9685

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

31.6

693

4327

XG466

NOMESCO Finland

Sleep oxymetry

2.1

31.6

300

1443

H02AB07

ATC

prednisone; oral

1.5

31.6

1284

9180

C05AA08

ATC

fluocortolone; rectal, topical

1.5

31.5

1271

9072

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

31.4

567

3363

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.9

31.4

416

2249

R32

ICD-10 Finland

Unspecified urinary incontinence

2.1

31.3

294

1408

J01FA10

ATC

azithromycin; systemic

1.3

31.3

5299

46611

R50.9

ICD-10 Finland

Fever, unspecified

1.4

31.2

1345

9717

SPAT1325

SPAT

Vaccination

1.3

31.2

3269

27088

XF402

NOMESCO Finland

ECG with work load test

1.5

31.2

1012

6914

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

31.2

387

2049

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

31.0

738

4704

N03AF02

ATC

oxcarbazepine; oral

2.1

30.9

303

1475

XF606

NOMESCO Finland

Ortostatic test

4.0

30.8

219

P25

ICPC

Phase of life problem adult

2.0

30.7

345

1765

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.6

30.7

102

288

A07AA02

ATC

nystatin; oral

1.7

30.6

574

3440

N06AA10

ATC

nortriptyline; systemic

2.4

30.6

204

846

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

30.6

517

3010

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.7

30.6

265

A06AC51

ATC

ispaghula, combinations; oral

1.8

30.6

474

2691

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

30.6

433

2392

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

30.5

1795

13678

S22

ICPC

Nail symptom/complaint

1.7

30.5

595

3605

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

30.4

2333

18512

EBA00

NOMESCO Finland

Extraction of tooth

1.3

30.4

3193

26450

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

30.3

757

4881

F33

ICD-10 Finland

Recurrent depressive disorder

2.5

30.2

191

774

G04BD07

ATC

tolterodine; oral

1.8

30.1

473

2697

G24.5

ICD-10 Finland

Blepharospasm

58.5

30.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

30.0

1632

12275

N05AF01

ATC

flupentixol; systemic

2.7

29.9

163

614

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

29.8

1094

7663

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.8

29.7

152

554

N30

ICD-10 Finland

Cystitis

1.6

29.7

728

4673

N06AA04

ATC

clomipramine; systemic

2.6

29.6

173

675

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

29.6

443

2490

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.5

29.4

182

730

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

29.4

3377

28270

ZX114

NOMESCO Finland

Intramuscular

2.9

29.4

139

486

A03

ICPC

Fever

1.4

29.3

1385

10167

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

29.3

1739

13264

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

29.2

913

6187

WX780

NOMESCO Finland

Remote monitoring CPAP

1.9

29.2

377

2022

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

29.2

310

1555

D21

ICPC

Swallowing problem

2.7

29.2

156

582

SPAT1360

SPAT

Extensive global examination

1.6

29.1

668

4218

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

29.0

974

6702

SPAT1211

SPAT

Application of soft bandage

1.6

28.9

815

5400

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

28.9

2706

22048

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

28.8

665

4207

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

28.8

1670

12688

A01AB09

ATC

miconazole; local oral

1.6

28.7

811

5375

H13

ICPC

Plugged feeling ear

1.4

28.7

1818

14001

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

28.7

2436

19583

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.3

28.6

106

321

S21

ICPC

Skin texture symptom/complaint

1.4

28.6

1319

9638

H01

ICPC

Ear pain/earache

1.5

28.5

976

6738

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

28.3

3591

30389

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

28.3

2393

19221

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

28.3

835

5589

SDA03

NOMESCO Finland

Periodontal treatment

1.3

28.3

3566

30159

H02AA02

ATC

fludrocortisone; oral

3.7

28.2

238

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

28.2

1103

7819

M43.1

ICD-10 Finland

Spondylolisthesis

1.9

28.1

377

2047

J46

ICD-10 Finland

Status asthmaticus

2.1

28.0

280

1375

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.5

27.9

176

712

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

27.9

695

4476

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

27.9

2015

15823

S04

ICPC

Lump/swelling localized

1.5

27.8

925

6349

R33

ICD-10 Finland

Retention of urine

1.6

27.8

705

4560

D09

ICPC

Nausea

1.9

27.8

382

2091

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.2

27.8

245

1146

G25.6

ICD-10 Finland

Drug-induced tics and other tics of organic origin

282.3

27.8

G54.0

ICD-10 Finland

Brachial plexus disorders

2.3

27.7

221

992

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

4.2

27.6

175

N39.3

ICD-10 Finland

Stress incontinence

1.6

27.6

693

4472

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.2

27.5

232

1066

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

27.5

2370

19077

C07AA07

ATC

sotalol; systemic

1.9

27.5

354

1898

AA40B, ,

NOMESCO Finland

4.5

27.5

151

M01AH02

ATC

rofecoxib; oral

1.4

27.4

1201

8691

R06AX22

ATC

ebastine; oral

1.4

27.4

1483

11132

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

27.3

3145

26274

U04

ICPC

Incontinence urine

1.7

27.3

524

3160

G43

ICD-10 Finland

Migraine

1.9

27.2

370

2018

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

27.2

667

4280

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.4

27.1

186

783

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

27.1

6050

54532

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

27.0

198

858

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

26.9

605

3802

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

26.8

1142

8221

XKC03

NOMESCO Finland

Water cystometry

2.0

26.8

294

1493

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.1

26.7

111

361

N76.0

ICD-10 Finland

Acute vaginitis

1.7

26.7

457

2672

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

26.6

1245

9113

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

26.6

1806

14040

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

26.5

142

531

SPAT1097

SPAT

Recording of ECG

1.4

26.4

1388

10361

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

26.4

742

4912

P73

ICPC

Affective psychosis

5.1

26.3

109

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.5

26.3

250

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.9

26.1

120

413

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

26.1

259

1268

N05AE04

ATC

ziprasidone; systemic

4.4

25.8

146

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

25.8

4122

35721

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

25.7

2708

22340

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

261.3

25.7

SBB10

NOMESCO Finland

Dental impressions

1.7

25.5

521

3194

N05AL01

ATC

sulpiride; systemic

2.6

25.4

148

577

N89

ICPC

Migraine

2.1

25.4

246

1194

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

25.4

766

5149

U01

ICPC

Dysuria/painful urination

1.6

25.3

701

4624

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

25.3

621

3984

C10AA01

ATC

simvastatin; oral

1.2

25.3

4086

35434

G04CB01

ATC

finasteride; oral

1.5

25.1

942

6616

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

25.1

678

4448

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

25.1

1195

8771

W19

ICD-10 Finland

Unspecified fall

1.5

25.1

865

5978

L05

ICPC

Flank/axilla symptom/complaint

1.6

25.0

546

3404

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

25.0

356

1970

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

25.0

9001

85359

P72

ICPC

Schizophrenia

2.5

25.0

154

617

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.5

25.0

163

671

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.9

24.9

115

397

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

24.9

827

5670

D07AA02

ATC

hydrocortisone; topical

1.4

24.9

1169

8558

L19

ICPC

Muscle symptom/complaint NOS

2.0

24.8

263

1319

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

24.8

628

4059

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.9

24.8

111

ZXA10

NOMESCO Finland

Bilateral

1.3

24.7

1732

13513

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

24.7

1020

7296

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

24.7

907

6346

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

24.5

2355

19183

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

24.5

486

2958

K08.80

ICD-10 Finland

Toothache NOS

1.5

24.4

708

4716

H02AB04

ATC

methylprednisolone; systemic

1.4

24.4

1307

9780

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

24.4

627

4066

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

24.4

695

4614

SPAT1043

SPAT

Audiometry

1.4

24.3

974

6927

XA402

NOMESCO Finland

ENMG

2.1

24.3

226

1080

G93.3

ICD-10 Finland

Postviral fatigue syndrome

4.7

24.2

117

N06AX18

ATC

reboxetine; oral

2.8

24.1

119

426

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.3

24.1

184

812

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

24.1

771

5246

N05AC02

ATC

thioridazine; oral

2.4

24.1

167

707

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

24.1

1990

15888

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

24.0

309

1656

H50.52

ICD-10 Finland

Exophoria

3.0

24.0

106

357

D19

ICPC

Teeth/gum symptom/complaint

1.3

24.0

2405

19688

H53.2

ICD-10 Finland

Diplopia

1.9

23.9

293

1545

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

23.9

312

1680

R15

ICD-10 Finland

Faecal incontinence

2.0

23.9

278

1441

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

23.9

690

4594

A01AB04

ATC

amphotericin B; local oral

1.7

23.8

430

2551

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

23.8

6365

58090

S22.3

ICD-10 Finland

Fracture of rib

1.6

23.7

600

3877

R03AC13

ATC

formoterol; inhalant

1.7

23.7

456

2753

XQ800

NOMESCO Finland

Prick test

1.6

23.7

592

3815

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

23.6

2496

20565

S02

ICPC

Pruritus

1.9

23.6

314

1702

C07AB02

ATC

metoprolol; systemic

1.3

23.5

1869

14833

R26.0

ICD-10 Finland

Ataxic gait

5.6

23.4

R44.1

ICD-10 Finland

Visual hallucinations

4.2

23.4

145

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

23.4

166

710

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

23.4

261

1334

R49.08

ICD-10 Finland

Other specified dysphonia

2.1

23.2

209

987

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

23.1

219

1054

ZXA00

NOMESCO Finland

Right side

1.3

23.1

2462

20295

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

23.1

1643

12837

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

23.1

832

5798

H29

ICPC

Ear symptom/complaint other

1.4

23.1

1040

7555

R01AD01

ATC

beclometasone; nasal

1.4

23.0

1317

9954

A02BA04

ATC

nizatidine; systemic

1.5

23.0

684

4581

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.8

23.0

118

432

R31

ICD-10 Finland

Unspecified haematuria

1.5

22.9

891

6299

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.2

22.9

182

817

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

22.8

439

2649

SPAT1252

SPAT

Overall medication plan or its review

1.6

22.8

624

4104

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

22.7

2019

16258

N02AA05

ATC

oxycodone; systemic

1.3

22.7

1610

12567

E66.8

ICD-10 Finland

Other obesity

1.7

22.7

441

2669

R06AE09

ATC

levocetirizine; oral

1.4

22.7

1191

8877

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

22.7

675

4522

ZXE00

NOMESCO Finland

One hour or less

1.2

22.6

3558

30663

N27

ICPC

Fear of neurological disease other

2.3

22.5

163

703

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

22.5

2090

16922

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

22.4

523

3314

UJD02

NOMESCO Finland

Gastroscopy

1.7

22.4

425

2556

U71

ICPC

Cystitis/urinary infection other

1.6

22.4

592

3864

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

22.4

3453

29686

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

22.3

405

2406

C10AA07

ATC

rosuvastatin; oral

1.3

22.3

2919

24636

E03

ICD-10 Finland

Other hypothyroidism

1.6

22.3

543

3477

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.3

22.2

170

751

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

22.2

1121

8298

-1, ,

NOMESCO Finland

1.3

22.2

2812

23638

L84

ICPC

Back syndrome without radiat pain

1.7

22.2

422

2538

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.9

22.2

164

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

22.1

2063

16711

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

22.1

407

2428

SPAT1101

SPAT

Orthostatic test

1.7

22.1

413

2475

OAB93, ,

SPAT

1.7

22.1

401

2384

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

21.9

426

2579

N05AX15

ATC

cariprazine; oral

5.5

21.9

R49.03

ICD-10 Finland

Atrophic dysphonia

2.6

21.9

127

495

H92.0

ICD-10 Finland

Otalgia

1.6

21.9

489

3068

WZC00, ,

SPAT

1.4

21.8

850

6009

R30.1

ICD-10 Finland

Vesical tenesmus

2.1

21.8

201

958

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

21.8

902

6450

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

21.8

902

6450

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.3

21.8

162

708

F29

ICPC

Eye symptom/complaint other

1.5

21.7

821

5773

R30.0

ICD-10 Finland

Dysuria

1.8

21.7

358

2072

SPAT1284

SPAT

Extensive health certificate

2.0

21.7

231

1162

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.1

21.7

293

R4130

NOMESCO Finland

Speech therapy

2.0

21.6

219

1082

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

21.6

2179

17820

M01AX05

ATC

glucosamine; oral

1.3

21.6

1854

14854

H93.1

ICD-10 Finland

Tinnitus

1.5

21.6

598

3945

R06.2

ICD-10 Finland

Wheezing

1.7

21.5

373

2188

R83

ICPC

Respiratory infection other

1.3

21.5

1967

15884

L04

ICPC

Chest symptom/complaint

1.6

21.5

544

3514

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.7

21.5

177

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.9

21.4

282

1524

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

21.4

367

2148

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

21.3

886

6340

SPAT1237

SPAT

Psychotherapy

3.8

21.2

165

SPAT1167

SPAT

Insertion of urinary catheter

1.9

21.2

290

1586

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

21.2

963

7000

G43.3

ICD-10 Finland

Complicated migraine

2.5

21.2

135

550

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

21.2

684

4660

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

21.2

1548

12128

G04BD09

ATC

trospium; oral

2.0

21.2

243

1255

M15

ICD-10 Finland

Polyarthrosis

1.6

21.2

474

2975

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

21.1

171

774

E000001, ,

ATC

1.3

21.1

1701

13506

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

21.1

1089

8089

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

21.1

462

2884

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.6

20.9

120

465

SPAT1283

SPAT

Restricted health certificate

1.4

20.9

1190

8983

N05BA02

ATC

chlordiazepoxide; systemic

2.1

20.8

205

1002

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.4

20.8

224

SFA00

NOMESCO Finland

Small restoration

1.4

20.8

1168

8797

G04BD11

ATC

fesoterodine; oral

1.9

20.7

270

1454

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

20.7

526

3401

A07EA06

ATC

budesonide; oral, local oral

1.8

20.7

309

1737

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

6.2

20.6

P28

ICPC

Limited function/disability (P)

3.1

20.6

276

T90

ICPC

Diabetes non-insulin dependent

1.3

20.6

2165

17783

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

20.4

878

6320

R52.1

ICD-10 Finland

Chronic intractable pain

2.9

20.4

336

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

4.2

20.4

126

B37.0

ICD-10 Finland

Candidal stomatitis

2.7

20.3

111

420

N02AJ13

ATC

tramadol and paracetamol; systemic

2.0

20.2

205

1013

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.7

20.2

343

2001

ZYC01, ,

SPAT

1.5

20.2

717

4980

G24

ICD-10 Finland

Dystonia

32.6

20.1

N05CD02

ATC

nitrazepam; oral

2.3

20.1

154

682

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

20.1

510

3299

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

20.1

439

2740

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

20.0

340

1986

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

19.9

812

5788

M77.4

ICD-10 Finland

Metatarsalgia

1.6

19.9

499

3217

SPAT1281

SPAT

Other administrative function

1.5

19.8

672

4623

J02AC02

ATC

itraconazole; systemic

1.3

19.8

1531

12078

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

19.8

2031

16620

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.0

19.8

293

AAG10

NOMESCO Finland

Stereotactic intracranial destruction of nucleus or nerve tract

+∞

19.8

R06AX13

ATC

loratadine; oral

1.3

19.7

1219

9311

M54.8

ICD-10 Finland

Other dorsalgia

1.7

19.7

384

2327

G24.0

ICD-10 Finland

Drug-induced dystonia

73.6

19.7

ZXA05

NOMESCO Finland

Left side

1.3

19.7

2254

18690

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

19.7

3612

31510

L84

ICD-10 Finland

Corns and callosities

1.8

19.6

307

1750

K58

ICD-10 Finland

Irritable bowel syndrome

2.0

19.6

213

1080

P98

ICPC

Psychosis NOS/other

3.6

19.5

175

K03.66

ICD-10 Finland

Tooth plaque

1.5

19.5

613

4153

D07AD01

ATC

clobetasol; topical

1.3

19.5

1453

11406

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

19.5

4266

37851

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

19.4

495

3203

R26

ICD-10 Finland

Abnormalities of gait and mobility

5.4

19.4

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.7

19.4

338

1987

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

3.7

19.4

162

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

3.1

19.4

260

M70.7

ICD-10 Finland

Other bursitis of hip

1.9

19.3

239

1266

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

19.3

998

7411

R03AK11

ATC

formoterol and fluticasone; inhalant

2.0

19.3

220

1134

T83

ICPC

Overweight

2.1

19.3

172

810

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.0

19.3

211

1072

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.0

19.3

212

1079

R47.1

ICD-10 Finland

Dysarthria and anarthria

2.9

19.3

319

M75

ICD-10 Finland

Shoulder lesions

1.7

19.2

375

2273

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

3.8

19.2

154

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

19.2

844

6098

ZY000

NOMESCO Finland

Hospital inpatient

2.7

19.2

105

398

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.3

19.2

142

620

OAA65, ,

SPAT

1.4

19.1

1048

7856

Z00.8

ICD-10 Finland

Other general examinations

1.5

19.1

645

4435

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

19.1

268

1479

IAB01, ,

SPAT

4.6

19.1

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.0

19.1

210

1070

S94

ICPC

Ingrowing nail

2.2

19.0

152

685

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

19.0

1345

10476

SPAT1251

SPAT

Organisation of medication

1.8

19.0

309

1781

N07CA01

ATC

betahistine; oral

1.5

19.0

651

4488

R01AD05

ATC

budesonide; nasal

1.5

19.0

633

4342

IHZ04, ,

SPAT

2.9

18.9

317

L09

ICPC

Arm symptom/complaint

1.6

18.8

404

2510

F48.0

ICD-10 Finland

Neurasthenia

5.1

18.8

A27

ICPC

Fear of other disease NOS

1.6

18.8

431

2722

J01FF01

ATC

clindamycin; systemic

1.2

18.8

2391

20050

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

+∞

18.8

C10AC01

ATC

colestyramine; oral

1.9

18.7

247

1337

R41.0

ICD-10 Finland

Disorientation, unspecified

1.8

18.7

266

1474

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

18.7

1188

9110

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

18.7

2295

19166

F22.0

ICD-10 Finland

Delusional disorder

2.3

18.7

133

571

J01MA06

ATC

norfloxacin; oral

1.3

18.7

1153

8804

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

18.7

204

1037

J01MA12

ATC

levofloxacin; systemic

1.3

18.6

1630

13068

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.5

18.6

119

487

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

18.5

1756

14219

F32.8

ICD-10 Finland

Other depressive episodes

2.3

18.5

132

567

N06BA12

ATC

lisdexamfetamine; oral

3.3

18.5

211

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

4.9

18.5

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.0

18.4

205

1049

R41.3

ICD-10 Finland

Other amnesia

1.8

18.4

270

1511

J01FA09

ATC

clarithromycin; systemic

1.2

18.3

2706

23046

N02CC07

ATC

frovatriptan; oral

1.8

18.3

280

1587

R49.01

ICD-10 Finland

Functional dysphonia

1.8

18.3

259

1434

N05AD03

ATC

melperone; systemic

2.6

18.3

106

414

R4120, ,

SPAT

2.8

18.2

329

N04BC02

ATC

pergolide; oral

44.1

18.2

N05AH05

ATC

asenapine; oral

7.1

18.2

SGA01

NOMESCO Finland

Emergency treatment

1.3

18.2

1246

9660

EB1VA, ,

NOMESCO Finland

1.4

18.2

1006

7553

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.0

18.1

199

1013

N19

ICPC

Speech disorder

2.5

18.1

114

463

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

2.9

18.1

292

C01CA01

ATC

etilefrine; systemic

3.2

18.1

229

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

18.1

657

4582

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

18.1

192

966

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.1

18.1

180

885

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

18.1

755

5405

-, ,

ICD-10 Finland

2.0

18.1

203

1042

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

18.0

272

1535

L99

ICPC

Musculoskeletal disease other

2.0

18.0

195

988

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

18.0

914

6766

K80

ICPC

Cardiac arrhythmia NOS

1.4

18.0

716

5080

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

17.9

966

7219

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

4.7

17.9

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

17.9

798

5780

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.2

17.8

150

691

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.2

17.8

145

659

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

17.8

593

4065

SPAT1104

SPAT

Monitoring of emergency patient

1.5

17.8

573

3901

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

17.8

284

1629

Z08

ICPC

Social welfare problem

2.5

17.8

113

461

F51.1

ICD-10 Finland

Nonorganic hypersomnia

7.2

17.8

IEY01

NOMESCO Finland

Psychoeducation, individual

3.4

17.7

182

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

17.7

667

4684

DQD34

NOMESCO Finland

Treatment of spasmodic dysfonia

13.7

17.7

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.7

17.7

363

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

17.6

524

3509

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

17.6

432

2772

K04

ICPC

Palpitations/awareness of heart

1.6

17.6

452

2931

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

17.6

1696

13752

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

17.6

1294

10128

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

17.6

420

2678

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

17.6

380

2365

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

17.6

513

3422

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

17.6

377

2342

S20.2

ICD-10 Finland

Contusion of thorax

1.6

17.6

416

2647

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

17.6

1029

7792

XF404

NOMESCO Finland

Ambulatory ECG

1.4

17.6

770

5560

AA5QN, ,

NOMESCO Finland

95.2

17.5

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.1

17.5

154

722

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

6.3

17.5

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

17.5

639

4460

L11

ICPC

Wrist symptom/complaint

1.4

17.5

726

5190

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.8

17.5

259

1454

R29

ICPC

Respiratory symptom/complaint other

1.5

17.5

555

3769

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

6.5

17.4

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

17.4

3020

26119

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

17.4

2140

17852

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.4

17.4

119

502

M01AB55

ATC

diclofenac, combinations; oral

1.5

17.4

589

4052

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

17.4

155

731

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.1

17.4

240

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.3

17.4

126

546

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.8

17.4

310

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

17.3

2031

16853

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.5

17.3

106

425

D02

ICPC

Abdominal pain epigastric

1.5

17.3

512

3426

IER01

NOMESCO Finland

Psychoeducation, group

3.7

17.3

147

N02CC05

ATC

almotriptan; oral

1.8

17.3

276

1584

K04.08

ICD-10 Finland

Other specified pulpit

1.5

17.3

546

3705

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.7

17.2

339

DHB50

NOMESCO Finland

Turbinoplasty

1.9

17.2

199

1032

C08CA01

ATC

amlodipine; oral

1.2

17.2

3597

31665

IGV01

NOMESCO Finland

Psychiatric network contact

3.0

17.2

252

A85

ICPC

Adverse effect medical agent

2.5

17.2

102

403

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.7

17.2

351

N02CC04

ATC

rizatriptan; oral

1.6

17.2

408

2599

SPAT1262

SPAT

Handing over of treatment supplies

1.3

17.2

1542

12392

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.6

17.1

363

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

17.1

398

2522

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.4

17.1

119

506

SPAT1050

SPAT

Extensive neurological examination

2.0

17.1

190

972

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

17.1

1059

8086

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

17.0

1345

10628

G50.1

ICD-10 Finland

Atypical facial pain

2.1

17.0

155

737

J01DA09

ATC

[U] cefadroxil

1.2

17.0

2250

18916

D07AB08

ATC

desonide; topical

1.4

17.0

900

6706

IGY99, ,

SPAT

2.6

17.0

376

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.6

17.0

382

S80.0

ICD-10 Finland

Contusion of knee

1.5

17.0

584

4030

U13

ICPC

Bladder symptom/complaint other

1.8

17.0

260

1475

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.1

16.9

228

J05AB01

ATC

aciclovir; systemic

1.3

16.9

1885

15545

D03

ICPC

Heartburn

1.7

16.9

295

1737

WX722

NOMESCO Finland

PEEP

1.6

16.9

377

2366

G44.0

ICD-10 Finland

Cluster headache syndrome

2.6

16.8

367

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

16.8

368

2300

H57.1

ICD-10 Finland

Ocular pain

1.7

16.7

290

1705

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

16.7

349

2155

K29.7

ICD-10 Finland

Gastritis, unspecified

1.7

16.6

311

1866

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

16.6

1445

11563

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

16.5

1003

7633

EB1AA, ,

SPAT

1.5

16.5

527

3584

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

16.5

396

2530

N04AA01

ATC

trihexyphenidyl; oral

27.5

16.5

X58

ICD-10 Finland

Exposure to other specified factors

1.3

16.5

1120

8668

H81.3

ICD-10 Finland

Other peripheral vertigo

1.8

16.5

245

1378

F05.9

ICD-10 Finland

Delirium, unspecified

2.0

16.4

181

924

TQW40, ,

SPAT

1.5

16.4

604

4225

F45.0

ICD-10 Finland

Somatization disorder

3.6

16.4

148

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.1

16.4

212

R75

ICPC

Sinusitis acute/chronic

1.6

16.4

374

2361

H02.3

ICD-10 Finland

Blepharochalasis

1.5

16.4

567

3919

130

Kela drug reimbursment

Malignant tumour

0.6

16.3

364

5653

T82

ICPC

Obesity

1.7

16.3

301

1799

IHZ07, ,

SPAT

3.3

16.3

187

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

4.5

16.3

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

16.3

842

6250

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.5

16.3

102

414

C01DA14

ATC

isosorbide mononitrate; oral

1.3

16.3

1372

10932

R07.0

ICD-10 Finland

Pain in throat

1.5

16.2

532

3636

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.2

16.2

128

575

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

16.2

480

3212

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.4

16.2

111

469

G04CB02

ATC

dutasteride; oral

1.5

16.2

599

4194

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.7

16.1

270

1572

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

4.9

16.1

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.8

16.1

235

1315

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

5.3

16.0

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

5.3

16.0

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

16.0

1077

8320

S01.0

ICD-10 Finland

Open wound of scalp

1.4

16.0

635

4503

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

16.0

460

3061

F05

ICPC

Visual disturbance other

1.8

15.9

256

1473

M35.7

ICD-10 Finland

Hypermobility syndrome

2.3

15.9

114

492

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.4

15.9

103

425

P15

ICPC

Chronic alcohol abuse

1.9

15.8

209

1133

S97

ICPC

Chronic ulcer skin

1.5

15.8

511

3482

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.5

15.8

372

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.0

15.8

159

786

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

15.8

494

3346

ACC51

NOMESCO Finland

Release of median nerve

1.4

15.7

616

4358

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.7

15.7

283

1681

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

15.7

523

3587

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.3

15.7

118

520

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

3.2

15.7

192

R25.3

ICD-10 Finland

Fasciculation

3.7

15.6

134

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

15.6

342

2137

F60.5

ICD-10 Finland

Anankastic personality disorder

2.6

15.6

340

M19.8

ICD-10 Finland

Other specified arthrosis

1.6

15.5

327

2023

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.6

15.5

329

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

15.5

197

1055

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

15.5

2156

18198

R06.4

ICD-10 Finland

Hyperventilation

2.2

15.5

132

612

R07

ICPC

Sneezing/nasal congestion

1.5

15.5

476

3211

M76.0

ICD-10 Finland

Gluteal tendinitis

1.9

15.5

180

936

S01

ICPC

Pain/tenderness of skin

1.6

15.5

388

2504

N03AX14

ATC

levetiracetam; systemic

1.8

15.5

233

1316

183

Kela drug reimbursment

Lamotrigin and topiramate

2.8

15.4

274

WX110, ,

SPAT

1.5

15.4

452

3021

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

4.5

15.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

15.4

499

3405

C03DA01

ATC

spironolactone; oral

1.3

15.3

1032

7971

N05AB01

ATC

dixyrazine; systemic

2.4

15.3

103

432

R07.2

ICD-10 Finland

Precordial pain

1.9

15.3

183

961

IFA01, ,

SPAT

7.0

15.2

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.3

15.2

108

464

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.8

15.2

208

1141

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.6

15.2

350

K29

ICPC

Cardiovascular sympt/complt other

1.6

15.2

382

2467

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

15.2

527

3644

C09CA01

ATC

losartan; oral

1.2

15.2

2316

19731

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.6

15.2

326

2028

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

15.2

707

5158

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.2

15.2

124

566

G01AF05

ATC

econazole; vaginal

1.4

15.1

599

4246

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

15.1

361

2304

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

15.1

455

3059

SPAT1139

SPAT

Nutrition survey

1.7

15.0

277

1657

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

15.0

2105

17778

R81

ICPC

Pneumonia

1.7

14.9

292

1774

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

14.9

567

3989

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

4.8

14.9

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.0

14.9

166

851

SPAT1285

SPAT

Provision of consultation response

1.5

14.9

445

2985

SPAT1336

SPAT

Request for examination

1.6

14.9

307

1891

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

14.9

751

5553

F32.0

ICD-10 Finland

Mild depressive episode

1.8

14.8

200

1092

C01CA24

ATC

epinephrine; parenteral

1.5

14.8

455

3069

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.9

14.8

190

1021

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.6

14.8

365

2346

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.8

14.8

213

1187

SPAT1051

SPAT

Guidance regarding sleep disorders

2.1

14.8

133

631

IAA02, ,

SPAT

5.9

14.8

S20

ICPC

Corn/callosity

1.9

14.7

177

931

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

14.7

433

2894

F61

ICD-10 Finland

Mixed and other personality disorders

3.9

14.7

112

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

14.6

659

4782

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

+∞

14.6

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

14.6

565

3990

R03BC03

ATC

nedocromil; inhalant

1.4

14.5

561

3959

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

4.9

14.5

S16

ICPC

Bruise/contusion

1.7

14.5

264

1575

M01AX01

ATC

nabumetone; oral

1.6

14.5

351

2249

C09CA06

ATC

candesartan; oral

1.2

14.5

2047

17296

S10

ICPC

Boil/carbuncle

1.5

14.5

457

3102

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

4.8

14.4

OAB44, ,

SPAT

1.4

14.4

573

4065

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

14.4

2049

17319

UJH02

NOMESCO Finland

Anoscopy

1.6

14.4

343

2188

SPAT1210

SPAT

Application of cast or individual aid

1.6

14.4

336

2133

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.0

14.4

213

IAA01, ,

SPAT

3.3

14.3

157

XA420

NOMESCO Finland

Extensive sleep examination

2.4

14.3

385

G03FA01

ATC

norethisterone and estrogen; systemic

1.3

14.3

1151

9111

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

14.3

886

6764

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

14.2

315

1974

IFA99, ,

SPAT

4.9

14.2

ZXD20

NOMESCO Finland

Day surgery

1.3

14.2

1060

8302

L20

ICPC

Joint symptom/complaint NOS

1.6

14.2

305

1897

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

4.7

14.2

S70.0

ICD-10 Finland

Contusion of hip

1.6

14.2

316

1984

K04.0

ICD-10 Finland

Pulpitis

1.4

14.2

660

4814

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

14.2

546

3852

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

14.1

776

5814

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

14.1

1240

9921

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

14.1

180

966

WZC30, ,

SPAT

1.5

14.1

448

3043

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.6

14.1

322

DFF00

NOMESCO Finland

Pure tone audiometry

1.3

14.1

855

6506

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.7

14.0

263

1582

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

14.0

715

5298

29580

ICD-8 Finland

Schizophrenia, Other

3.6

13.9

121

SPAT1235

SPAT

Mental health, emotional support

2.9

13.9

222

R03AC12

ATC

salmeterol; inhalant

1.5

13.9

371

2428

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

1.9

13.9

170

900

N05AF05

ATC

zuclopenthixol; systemic

2.7

13.9

272

K85

ICPC

Elevated blood pressure

1.3

13.9

1424

11607

K02

ICD-10 Finland

Dental caries

1.4

13.9

538

3798

G03DB01

ATC

dydrogesterone; oral

1.3

13.9

931

7185

H26.4

ICD-10 Finland

After-cataract

1.3

13.9

900

6914

R39.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the urinary system

2.7

13.9

284

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

13.8

418

2811

F10.24

ICD-10 Finland

Alcohol depence active use

2.2

13.8

110

497

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.5

13.8

374

2457

J45.8

ICD-10 Finland

Mixed asthma

1.7

13.8

252

1504

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

13.8

570

4072

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

53.4

13.8

R44.0

ICD-10 Finland

Auditory hallucinations

3.4

13.8

141

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.7

13.6

263

1593

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.0

13.6

149

760

T07

ICPC

Weight gain

2.2

13.6

106

475

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

2.9

13.6

220

G25.4

ICD-10 Finland

Drug-induced chorea

+∞

13.5

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.3

13.5

805

6105

E86

ICD-10 Finland

Volume depletion

1.8

13.5

198

1110

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

13.5

3129

27654

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

5.4

13.5

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.1

13.5

118

554

A01AB10

ATC

natamycin; local oral

1.7

13.5

236

1393

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.6

13.5

351

2287

D25

ICPC

Abdominal distension

1.9

13.5

156

812

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

13.4

390

2601

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.4

13.4

495

3463

B01AC04

ATC

clopidogrel; oral

1.3

13.4

1414

11560

A06AX04

ATC

linaclotide; oral

3.7

13.4

115

K44

ICD-10 Finland

Diaphragmatic hernia

2.5

13.4

330

X15

ICPC

Vaginal symptom/complaint other

1.7

13.4

256

1547

UJD10, ,

SPAT

1.8

13.4

185

1020

I95.9

ICD-10 Finland

Hypotension, unspecified

2.1

13.3

131

643

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

2.2

13.3

110

505

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

13.3

2173

18604

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

13.3

732

5486

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.6

13.3

343

2230

C08CA05

ATC

nifedipine; systemic

1.4

13.2

502

3531

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

13.2

2508

21772

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.2

13.2

165

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.9

13.2

170

916

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

13.2

1726

14449

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

3.5

13.2

126

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

13.1

383

2557

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.8

13.1

200

1135

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

13.1

1003

7880

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

13.1

928

7215

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

13.1

320

2054

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.9

13.1

166

890

ICB01, ,

SPAT

3.1

13.1

166

WX402

NOMESCO Finland

General anaesthesia

1.2

13.1

1740

14593

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.6

13.0

288

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.3

13.0

415

D07AC13

ATC

mometasone; topical

1.2

13.0

2483

21571

L18

ICPC

Muscle pain

1.6

12.9

325

2100

SPAT1244

SPAT

Occupational therapy

2.3

12.9

409

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.9

12.9

169

915

S09

ICPC

Infected finger/toe

1.7

12.9

257

1569

H02AB02

ATC

dexamethasone; systemic

0.7

12.9

553

7579

A07DA03

ATC

loperamide; oral

1.6

12.9

275

1708

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.6

12.9

285

1788

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.5

12.9

398

2691

N02CD02

ATC

galcanezumab; parenteral

3.8

12.8

100

N81.6

ICD-10 Finland

Rectocele

1.4

12.8

549

3947

R09.1

ICD-10 Finland

Pleurisy

2.0

12.8

140

714

K08.3

ICD-10 Finland

Retained dental root

1.4

12.8

609

4458

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.5

12.8

353

2329

K05.1

ICD-10 Finland

Chronic gingivitis

1.4

12.8

524

3738

G43.8

ICD-10 Finland

Other migraine

2.1

12.7

111

521

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.3

12.7

381

Z29

ICPC

Social problem NOS

1.9

12.7

158

842

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

1.9

12.7

157

835

N07BA03

ATC

varenicline; oral

1.5

12.7

336

2198

SPAT1377

SPAT

Polysomnography

1.6

12.7

258

1586

ZXH06, ,

SPAT

1.5

12.6

350

2312

M01AH03

ATC

valdecoxib; oral

1.4

12.6

490

3462

R44.3

ICD-10 Finland

Hallucinations, unspecified

3.0

12.6

175

R40.0

ICD-10 Finland

Somnolence

3.7

12.6

106

R25

ICD-10 Finland

Abnormal involuntary movements

15.4

12.6

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.1

12.6

160

OAB42, ,

SPAT

1.3

12.6

773

5892

M02AA15

ATC

diclofenac; topical

1.4

12.5

602

4414

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

12.5

454

3167

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.4

12.5

347

X14

ICPC

Vaginal discharge

2.0

12.5

136

693

R01AX03

ATC

ipratropium bromide; nasal

1.8

12.5

180

1005

G23.2

ICD-10 Finland

Multiple system atrophy, parkinsonian type [MSA-P]

+∞

12.5

3320A

ICD-9 Finland

Parkinson's disease, Paralysis agitans

+∞

12.5

G24.2

ICD-10 Finland

Idiopathic nonfamilial dystonia

+∞

12.5

R63.1

ICD-10 Finland

Polydipsia

4.1

12.5

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

12.5

613

4513

J01DA08

ATC

[U] cefaclor

1.3

12.4

754

5734

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.1

12.4

111

526

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

2.2

12.4

101

461

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

3.8

12.4

D01AE16

ATC

amorolfine; topical

1.3

12.4

983

7759

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

5.6

12.4

F60.8

ICD-10 Finland

Other specific personality disorders

3.0

12.4

177

A60

ICPC

General and Unspecified, Result test/procedure

1.5

12.4

354

2355

D50

ICD-10 Finland

Iron deficiency anaemia

1.8

12.4

170

936

L87

ICPC

Bursitis/tendinitis/synovitis NOS

2.0

12.4

124

614

N48.1

ICD-10 Finland

Balanoposthitis

1.8

12.4

173

958

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

12.3

449

3135

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

12.3

524

3765

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

12.3

749

5700

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

12.3

633

4695

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.2

12.3

102

470

D06AX01

ATC

fusidic acid; topical

1.3

12.3

725

5493

P58

ICPC

Psychological, Therapeutic counselling/listening

2.0

12.3

124

616

H02.4

ICD-10 Finland

Ptosis of eyelid

1.7

12.2

237

1439

SCA02

NOMESCO Finland

Preventive oral health care

1.3

12.2

746

5680

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.8

12.2

163

890

XA421

NOMESCO Finland

Nocturnal polygraphy

3.1

12.2

163

I50

ICD-10 Finland

Heart failure

1.6

12.2

254

1571

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

12.2

284

1805

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

12.2

372

2510

R52.0

ICD-10 Finland

Acute pain

1.6

12.2

249

1533

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

4.3

12.2

A10BJ02

ATC

liraglutide; parenteral

1.7

12.2

215

1274

B35.1

ICD-10 Finland

Tinea unguium

1.4

12.2

495

3529

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.4

12.1

471

3329

G01AA10

ATC

clindamycin; vaginal

1.3

12.1

1100

8833

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

12.1

306

1982

S06

ICPC

Rash localized

1.4

12.1

455

3198

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

12.1

380

2579

N94.1

ICD-10 Finland

Dyspareunia

2.3

12.1

384

R5599

NOMESCO Finland

Other rehabilitation service

1.7

12.1

216

1284

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.4

12.1

543

3939

F06.7

ICD-10 Finland

Mild cognitive disorder

1.7

12.0

239

1460

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

3.1

12.0

159

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.7

12.0

238

1453

N02CD03

ATC

fremanezumab; systemic

2.7

12.0

241

P02

ICPC

Acute stress reaction

1.5

12.0

321

2105

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.5

12.0

131

2448

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.5

12.0

358

2404

SPAT1106

SPAT

Acupuncture

2.5

12.0

276

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.3

11.9

355

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

2.4

11.9

349

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.6

11.9

294

1894

WX320

NOMESCO Finland

Spinalanesthesy

1.2

11.9

2123

18305

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.6

11.9

257

1604

A09

ICPC

Sweating problem

2.2

11.9

431

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.4

11.9

331

N02AC04

ATC

dextropropoxyphene; oral

1.6

11.9

290

1864

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

2.7

11.9

237

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

2.7

11.8

226

AN1

Coronary angiography

1.3

11.8

926

7298

M05BA04

ATC

alendronic acid; oral

1.3

11.8

753

5769

B07.9

ICD-10 Finland

Verruca simplex

1.6

11.8

261

1638

G72.9

ICD-10 Finland

Myopathy, unspecified

2.5

11.8

284

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.0

11.8

124

625

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.5

11.8

346

2315

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.5

11.8

357

2405

-50

ICPC

Medication/prescr/renewal

1.5

11.8

336

2235

H60.8

ICD-10 Finland

Other otitis externa

1.7

11.8

232

1415

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

1.9

11.8

155

843

TKC22

NOMESCO Finland

Catheterisation instruction

1.8

11.7

177

1003

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.6

11.7

260

1633

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

11.7

1173

9527

N41.1

ICD-10 Finland

Chronic prostatitis

1.8

11.7

169

945

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.5

11.7

268

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.0

11.7

129

662

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.5

11.7

385

2639

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

1.8

11.6

158

867

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.3

11.6

694

5265

R01AD11

ATC

triamcinolone; nasal

1.3

11.6

670

5057

B01AA03

ATC

warfarin; systemic

1.2

11.6

1647

13887

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

4.6

11.6

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.6

11.6

282

1810

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

3.2

11.6

137

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

11.5

471

3361

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

3.9

11.5

A02BA03

ATC

famotidine; systemic

1.6

11.5

293

1901

N05

ICPC

Tingling fingers/feet/toes

2.1

11.5

104

496

F51.5

ICD-10 Finland

Nightmares

8.6

11.5

G44.8

ICD-10 Finland

Other specified headache syndromes

2.1

11.5

108

523

F60.7

ICD-10 Finland

Dependent personality disorder

3.2

11.5

143

G24.1

ICD-10 Finland

Idiopathic familial dystonia

+∞

11.5

SXC06

NOMESCO Finland

Clinical work to produce sleep apnoea splint

3.3

11.4

128

J05AB11

ATC

valaciclovir; oral

1.3

11.4

1167

9498

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.6

11.4

250

1566

R09

ICPC

Sinus symptom/complaint

1.4

11.4

601

4475

ZXE22

NOMESCO Finland

Procedure duration at least 4 but less than 5 hours

4.7

11.4

H82

ICPC

Vertiginous syndrome

1.9

11.4

150

816

WZB00, ,

SPAT

1.4

11.4

554

4073

A46

ICD-10 Finland

Erysipelas

1.3

11.4

1215

9941

XJH00

NOMESCO Finland

Transanal ultrasonography

1.4

11.4

461

3285

UDM02

NOMESCO Finland

Sinoscopy

1.8

11.4

169

954

C08DA01

ATC

verapamil; systemic

1.5

11.4

329

2196

SPAT1238

SPAT

Brief therapy

2.0

11.4

116

579

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.3

11.3

382

K13.78

ICD-10 Finland

Other change in the oral mucosa

1.7

11.3

198

1170

XCK00

NOMESCO Finland

Perimetry

1.4

11.3

526

3837

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.1

11.3

107

519

L30.4

ICD-10 Finland

Erythema intertrigo

2.0

11.3

115

573

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.6

11.3

289

1877

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.7

11.3

222

1354

E66

ICD-10 Finland

Obesity

1.5

11.3

357

2427

K03.00

ICD-10 Finland

Approximal wear

1.4

11.3

507

3679

N02CD01

ATC

erenumab; parenteral

2.6

11.3

232

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.4

11.2

496

3588

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.6

11.2

281

1817

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.3

11.2

739

5690

AA1BG, ,

SPAT

1.9

11.2

131

686

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.0

11.2

109

535

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.3

11.2

756

5842

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.6

11.1

236

1468

AA1AA

NOMESCO Finland

Head X-ray examination

2.4

11.1

305

B03BA03

ATC

hydroxocobalamin; parenteral

1.4

11.1

464

3326

M01AB08

ATC

etodolac; oral

1.4

11.0

564

4179

ACC53

NOMESCO Finland

Release of ulnar nerve

2.0

11.0

113

565

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.2

11.0

432

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

1.7

11.0

193

1142

T05

ICPC

Feeding problem of adult

2.5

11.0

264

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.4

11.0

522

3822

I20.09

ICD-10 Finland

Unstable angina

1.4

11.0

454

3246

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.6

11.0

224

1379

C10AX09

ATC

ezetimibe; oral

1.2

11.0

1299

10749

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

4.4

11.0

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.9

10.9

128

670

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

10.9

765

5938

K05.30

ICD-10 Finland

Periodontitis complex

1.3

10.9

1153

9419

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

4.5

10.9

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

4.5

10.9

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.3

10.9

117

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.5

10.9

287

1877

D10

ICPC

Vomiting

1.5

10.9

372

2568

D01AC02

ATC

miconazole; topical

1.4

10.9

591

4421

N02CC06

ATC

eletriptan; oral

1.6

10.9

226

1399

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.3

10.8

333

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

1.8

10.8

143

779

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

2.6

10.8

231

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

3.1

10.8

143

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

10.8

271

1753

K27

ICPC

Fear cardiovascular disease other

2.2

10.8

397

J01MA14

ATC

moxifloxacin; systemic

1.3

10.8

704

5414

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

1.6

10.8

216

1325

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.4

10.7

400

2807

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.6

10.7

219

1349

F28

ICD-10 Finland

Other nonorganic psychotic disorders

4.0

10.7

M01AB01

ATC

indometacin; systemic, rectal

1.4

10.7

591

4432

G51.3

ICD-10 Finland

Clonic hemifacial spasm

4.4

10.7

AA1CG, ,

SPAT

2.2

10.7

379

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

10.7

486

3533

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

1.7

10.7

210

1281

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

10.7

202

1220

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.5

10.7

363

2505

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.4

10.7

468

3383

H91.1

ICD-10 Finland

Presbycusis

1.4

10.6

536

3963

J01AA07

ATC

tetracycline; systemic

1.3

10.6

1106

9021

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

2.7

10.6

199

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.4

10.6

503

3683

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

10.6

1874

16126

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

10.6

1560

13198

ZXY49

NOMESCO Finland

Other health care provider

3.5

10.6

100

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.6

10.5

246

1566

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.5

10.5

296

1965

K11.70

ICD-10 Finland

Hypoptyalism

2.6

10.5

223

ZA1.0

ICD-10 Finland

Shoulder region

1.7

10.5

190

1135

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.5

10.5

278

1822

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

1.7

10.5

184

1090

R19.5

ICD-10 Finland

Other faecal abnormalities

1.9

10.5

132

709

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

10.5

326

2211

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

10.4

819

6455

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.7

10.4

181

1069

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.7

10.4

177

1039

N07XX06

ATC

tetrabenazine; oral

110.1

10.4

F0232, G20,

ICD-10 Finland

+∞

10.4

R78

ICPC

Acute bronchitis/bronchiolitis

1.7

10.4

165

950

SBA00

NOMESCO Finland

Microbiological examinations

1.7

10.4

197

1191

C08CA13

ATC

lercanidipine; oral

1.2

10.4

1237

10238

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.8

10.4

147

819

S76

ICPC

Skin infection other

1.4

10.4

417

2969

SPAT1265

SPAT

Breathalyser

2.4

10.4

278

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.2

10.4

378

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

2.0

10.4

103

510

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.7

10.3

182

1079

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.4

10.3

514

3793

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

10.3

1080

8812

VALMI, ,

NOMESCO Finland

1.2

10.3

1915

16545

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.8

10.3

157

894

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

10.3

486

3557

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.5

10.3

334

2284

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

3.9

10.3

Z50.1

ICD-10 Finland

Other physical therapy

1.4

10.3

418

2982

D02AE01

ATC

carbamide; topical

1.4

10.3

489

3584

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.2

10.3

399

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.6

10.2

245

1569

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

3.3

10.2

112

U08

ICPC

Urinary retention

1.8

10.2

154

874

WX892

NOMESCO Finland

Monitored bed care

1.3

10.2

598

4526

A10BK03

ATC

empagliflozin; oral

1.3

10.2

765

5993

J01

ICD-10 Finland

Acute sinusitis

1.4

10.2

385

2709

A10BA02

ATC

metformin; oral

1.2

10.2

2442

21552

L57.0

ICD-10 Finland

Actinic keratosis

1.3

10.2

902

7216

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.5

10.2

329

2247

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.5

10.2

327

2231

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.6

10.2

202

1236

F01

ICPC

Eye pain

1.6

10.2

210

1298

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

2.1

10.1

460

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.6

10.1

237

1511

J37.0

ICD-10 Finland

Chronic laryngitis

1.6

10.1

249

1606

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.3

10.1

586

4430

R99

ICPC

Respiratory disease other

1.8

10.1

143

797

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.3

10.1

678

5236

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

10.0

850

6764

H61.2

ICD-10 Finland

Impacted cerumen

1.4

10.0

532

3966

D18

ICPC

Change in faeces/bowel movements

1.7

10.0

195

1187

C10AA04

ATC

fluvastatin; oral

1.3

10.0

722

5626

T86

ICPC

Hypothyroidism/myxoedema

1.5

10.0

326

2230

SPAT1168

SPAT

Catheterisation training

2.8

10.0

177

KED22

NOMESCO Finland

Transurethral resection of prostate

1.4

10.0

410

2930

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

2.4

10.0

289

UDC00

NOMESCO Finland

Ear microscopy

1.3

10.0

587

4446

G90.3

ICD-10 Finland

Multi-system degeneration

14.6

10.0

A02BX02

ATC

sucralfate; oral

1.5

10.0

308

2086

IEV99

NOMESCO Finland

Other psychiatric network intervention

3.3

10.0

114

H01.0

ICD-10 Finland

Blepharitis

1.4

9.9

469

3432

L01BC06

ATC

capecitabine; oral

0.5

9.9

121

2185

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.3

9.9

683

5289

S01GX08

ATC

ketotifen; ophthalmic

1.5

9.9

306

2071

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

9.9

367

2574

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.6

9.9

240

1542

L29.8

ICD-10 Finland

Other pruritus

1.9

9.9

112

581

N06AA22, ,

ATC

2.5

9.9

230

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

2.4

9.9

254

M13.9

ICD-10 Finland

Arthritis, unspecified

1.3

9.9

576

4358

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

2.7

9.8

190

R1250, ,

SPAT

1.8

9.8

136

753

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.3

9.8

674

5219

F06.0

ICD-10 Finland

Organic hallucinosis

4.2

9.8

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

9.8

753

5918

R61

ICD-10 Finland

Hyperhidrosis

2.2

9.8

348

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.8

9.8

130

710

M77.9

ICD-10 Finland

Enthesopathy, unspecified

1.6

9.8

223

1412

R04

ICPC

Breathing problem other

1.5

9.8

281

1874

IHZ19, ,

SPAT

3.6

9.8

R49.09

ICD-10 Finland

Unspecified dysphonia

2.1

9.8

440

S82

ICPC

Naevus/mole

1.2

9.8

1066

8740

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.6

9.8

199

1227

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.4

9.7

469

3444

L50.9

ICD-10 Finland

Urticaria, unspecified

1.5

9.7

260

1708

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.8

9.7

151

865

OAB38, ,

SPAT

2.1

9.7

421

N05BA05

ATC

potassium clorazepate; oral

2.2

9.7

356

J01AA04

ATC

lymecycline; systemic

1.3

9.7

954

7729

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

1.8

9.7

132

727

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.4

9.7

351

2452

P80

ICPC

Personality disorder

3.1

9.7

121

N88

ICPC

Epilepsy

2.7

9.7

186

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

1.5

9.7

305

2074

IEY05, ,

SPAT

7.3

9.7

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5885

38265

2.18

307.65

2.3

2.0

96.68

95.77

pmol/l

0.70

3125

19608

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6307

38155

2.56

307.65

3.3

2.9

110.63

132.33

ug/l

13.97

5749

35159

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4522

27932

2.06

276.34

2.4

2.1

177.25

212.71

u/l

2.22

4236

26100

(3021960) Folate [Moles/volume] in Serum or Plasma

3711

21786

2.07

255.91

1.6

1.5

20.38

20.46

nmol/l

0.11

3182

18518

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6499

46561

1.99

252.11

6.3

6.7

1.22

1.21

mmol/l

2.19

5575

39417

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6025

42146

1.97

249.54

5.8

6.0

1.21

mmol/l

1.76

5487

38268

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8643

69218

2.23

240.01

5.0

4.1

14.87

14.84

pmol/l

0.60

7892

62730

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3837

23383

1.99

233.70

2.4

2.3

2.79

2.99

mg/l

6.32

3230

20005

(3013707) Erythrocyte sedimentation rate by Westergren method

8443

67344

2.15

231.40

4.7

4.2

11.76

12.87

mm/h

11.08

7801

62138

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9728

82833

2.72

221.05

6.3

4.8

1.85

2.12

mu/l

4.40

8986

75556

(3015377) Calcium [Moles/volume] in Serum or Plasma

4706

31364

1.89

214.18

2.8

3.4

2.35

2.36

mmol/l

0.31

4064

27364

(3019309) Folate [Moles/volume] in Red Blood Cells

3016

17881

1.95

191.41

1.9

1.7

1200.72

1162.80

nmol/l

1.25

2276

13381

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8568

70433

2.04

191.16

7.5

7.7

76.25

78.79

u/l

7.12

8065

66261

(3031040) Bacteria [#/volume] in Urine by Automated count

7614

60703

1.86

179.03

6.0

4.6

1629.31

1651.93

e6/l

0.01

108

852

(3024561) Albumin [Mass/volume] in Serum or Plasma

5510

40241

1.75

171.56

4.4

4.8

35.84

35.28

g/l

12.34

5111

37282

(3018418) pH of Serum or Plasma

4075

27653

1.76

161.42

3.8

4.1

7.40

0.05

666

5284

(3037467) Urinalysis macro (dipstick) panel - Urine

7729

62908

1.80

157.64

5.3

4.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5184

38039

1.70

151.58

2.4

2.2

78.10

78.16

nmol/l

0.05

4622

33948

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2508

14960

1.88

150.55

2.6

3.3

0.82

0.81

mmol/l

4.27

2292

13996

(40760892) CBC W Ordered Manual Differential panel - Blood

5642

42613

1.68

145.60

6.1

6.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2447

14710

1.86

142.20

2.4

2.5

13.83

12.71

umol/l

10.82

2236

13652

(3013115) Eosinophils [#/volume] in Blood

6072

46920

1.67

141.97

6.3

6.0

0.19

e9/l

0.59

5322

40955

(3013826) Glucose [Moles/volume] in Serum or Plasma

6771

53845

1.69

141.61

5.0

4.7

6.60

6.74

mmol/l

7.68

6375

50390

(3006315) Basophils [#/volume] in Blood

5912

45475

1.66

139.76

5.9

5.8

0.04

e9/l

0.56

5086

39108

(3001604) Monocytes [#/volume] in Blood

5887

45345

1.65

137.43

5.9

5.8

0.58

0.59

e9/l

5.59

5080

39022

(3019550) Sodium [Moles/volume] in Serum or Plasma

10190

92600

2.70

134.62

21.5

17.2

139.64

139.65

mmol/l

0.14

10010

90277

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9974

89816

2.40

133.42

18.5

14.9

21.51

24.19

mg/l

14.62

8323

71768

(3023103) Potassium [Moles/volume] in Serum or Plasma

10202

92842

2.71

132.87

21.6

17.3

3.97

mmol/l

0.27

10006

90337

(3019198) Lymphocytes [#/volume] in Blood

5991

46616

1.64

132.03

6.0

5.9

1.89

1.93

e9/l

0.92

5280

41030

(3009466) Valproate [Moles/volume] in Serum or Plasma

407

1133

3.69

124.24

6.1

4.7

391.55

357.36

umol/l

4.48

366

955

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2709

17399

1.74

123.35

2.7

3.1

2.45

2.46

mmol/l

6.95

2369

15187

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2238

13613

1.81

122.77

2.4

2.5

2.39

2.32

g/l

7.38

2033

12567

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2903

19124

1.71

120.02

1.3

1.51

1.72

u/ml

0.33

736

5093

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2999

19939

1.70

119.78

1.7

23139591.95

33851577.04

pmol/l

0.55

2472

16351

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6066

47980

1.60

119.62

5.2

6.2

10.68

11.48

umol/l

7.20

5704

45495

(3013650) Neutrophils [#/volume] in Blood by Automated count

6532

52683

1.60

117.81

8.8

9.1

4.12

4.14

e9/l

0.21

5721

45860

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4703

35125

1.60

117.44

4.4

3.7

136.74

67.09

ng/l

0.33

3331

24640

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9329

82758

1.92

116.60

6.8

5.9

39.84

39.98

mmol/mol

0.76

8626

76133

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7013

57777

1.61

113.49

3.7

3.1

45.50

49.22

u/l

3.19

6499

53431

(3015736) pH of Urine

4751

35817

1.58

112.33

4.1

3.5

5.93

5.86

0.58

269

2380

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1655

9456

1.89

109.75

2.0

1.7

1.52

1.47

1.89

1447

8195

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3959

28851

1.59

106.68

2.7

2.6

56.17

62.14

u/l

1.37

3612

26562

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9638

87026

1.98

105.59

5.5

4.7

5.96

mmol/l

0.05

8824

78865

(3024666) Lithium [Moles/volume] in Serum or Plasma

207

385

5.46

105.42

13.0

11.8

0.65

0.62

mmol/l

0.61

185

353

(3035350) Ketones [Presence] in Urine by Test strip

5627

44530

1.55

104.41

4.5

3.8

0.00

estimate

3.45

1054

8866

(3021601) Nitrite [Presence] in Urine by Test strip

5617

44541

1.54

102.47

5.8

5.1

0.00

estimate

1.34

1026

8283

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2050

12794

1.74

100.52

2.5

2.6

22.86

22.17

1.41

1721

10869

(3009261) Glucose [Presence] in Urine by Test strip

5653

45026

1.53

100.03

4.5

3.8

0.00

estimate

0.17

1000

8104

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1141

5921

2.04

99.71

2.5

2.4

29.69

23.60

au/ml

0.67

439

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1059

5395

2.07

97.22

1.3

53.40

54.59

au/ml

0.05

308

(3011397) Hemoglobin [Presence] in Urine by Test strip

3045

21288

1.60

95.44

4.5

3.7

—

(3026008) Bacteria identified in Urine by Culture

3940

29277

1.54

94.21

3.7

3.2

—

(3019069) Monocytes/100 leukocytes in Blood

5383

42837

1.51

92.75

6.4

8.51

8.64

2.38

4987

39961

(3022096) Basophils/100 leukocytes in Blood

5216

41248

1.51

92.55

6.1

0.68

0.67

0.25

4823

38327

(3006504) Eosinophils/100 leukocytes in Blood

5355

42580

1.51

92.54

6.1

2.87

2.85

0.21

4959

39651

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2861

19880

1.60

91.24

1.8

1.7

1.10

1.26

mg/l

1.55

2140

15260

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1416

8128

1.85

91.24

2.1

2.2

363.02

375.92

nmol/l

1.66

1301

7445

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

528

2048

2.66

91.10

1.2

1.4

577.14

539.41

mg/l

0.23

490

1945

(40761511) CBC panel - Blood by Automated count

10034

92740

2.12

90.22

17.3

14.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

5474

43897

1.50

89.63

6.2

27.86

27.55

1.30

5083

41036

(3018010) Neutrophils/100 leukocytes in Blood

5406

43248

1.50

89.51

6.0

57.27

57.50

0.77

5021

40394

(3022217) INR in Platelet poor plasma by Coagulation assay

5433

43625

1.49

87.55

17.4

16.0

1.23

1.28

inr

3.30

1496

12497

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

471

1799

2.69

83.71

1.2

1.3

3.81

3.78

mmol/l

0.20

436

1687

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2282

15299

1.62

83.23

1.3

28.67

35.64

iu/ml

1.54

677

4887

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3668

27384

1.51

83.03

3.1

3.0

1209.11

1503.36

ng/l

3.02

3109

23651

(3007164) IgA [Mass/volume] in Serum or Plasma

2439

16653

1.60

82.35

1.5

2.26

2.46

g/l

6.28

1362

9964

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10196

95281

2.20

81.44

12.4

10.7

25.07

25.78

u/l

3.76

9869

91697

(36304419) Bacteria [Presence] in Urine

3383

24944

1.52

80.70

3.5

3.1

—

(3018095) Leukocytes [#/volume] in Urine

4214

32574

1.48

79.44

4.3

3.7

89.09

101.73

e6/l

0.34

3040

23120

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

456

1792

2.61

76.50

1.3

1.5

648.70

3308.54

e6/l

0.71

351

1462

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2210

14983

1.60

76.02

2.0

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

455

1793

2.61

75.90

1.3

1.4

9.68

35.41

e6/l

2.31

323

1391

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2137

14454

1.60

73.98

1.3

10.15

13.15

u/ml

1.15

786

5485

(3030467) Casts [#/volume] in Urine by Automated count

3425

25738

1.48

72.70

3.5

3.2

0.29

0.44

e6/l

5.87

2643

19629

(3019150) Specific gravity of Urine by Refractometry

2718

19506

1.53

71.99

5.2

4.2

1.02

kg/l

0.13

388

2996

(40768797) Stomach Pathology biopsy report

1918

12760

1.61

70.78

1.3

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

1824

12004

1.62

70.32

1.4

1.3

594.49

532.60

titre

0.53

356

2610

(3028707) Methadone [Presence] in Urine by Screen method

310

1049

3.01

68.97

2.5

2.6

—

(3048689) Calprotectin [Mass/mass] in Stool

1628

10479

1.65

68.40

2.0

2.2

136.54

137.24

ug/g

0.02

1267

8234

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9235

84515

1.63

68.01

16.5

14.0

79.41

79.15

ml/min/173m2

0.54

7753

69979

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9698

89938

1.75

67.32

5.6

5.0

2.67

2.73

mmol/l

9.18

8907

82481

(3044889) 12 lead EKG panel

7271

63394

1.45

66.83

4.5

3.9

—

(3002582) Erythrocytes [#/volume] in Urine

3635

28037

1.45

65.79

3.7

3.3

65.82

83.86

e6/l

0.61

2809

21538

(3044290) Cell count panel - Cerebral spinal fluid

414

1672

2.53

65.58

1.3

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

10403

98861

2.33

65.38

28.3

22.0

40.02

40.05

0.09

9753

92222

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3732

28967

1.44

65.12

3.2

30.47

34.83

u/l

4.55

3481

27394

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1578

10208

1.64

64.69

1.9

1.8

—

(3007461) Platelets [#/volume] in Blood

10404

98924

2.32

64.44

28.3

22.0

248.06

250.48

e9/l

3.55

10213

96318

(3035941) MCH [Entitic mass]

10404

98965

2.31

63.67

28.1

21.8

30.37

30.32

2.58

10291

97490

(3024731) MCV [Entitic volume]

10404

98971

2.31

63.56

28.1

21.9

91.40

91.17

6.33

10290

97497

(3026361) Erythrocytes [#/volume] in Blood

10404

98979

2.30

63.41

28.2

21.9

4.44

4.46

e12/l

3.90

10172

96079

(3000963) Hemoglobin [Mass/volume] in Blood

10405

98998

2.30

63.30

28.4

22.1

133.94

134.41

g/l

2.77

10289

97540

(3010813) Leukocytes [#/volume] in Blood

10403

98985

2.30

63.04

28.3

21.9

6.76

6.75

e9/l

0.20

10184

96059

(1002224) Polysomnography panel

638

3160

2.08

62.35

1.1

—

(3023368) Bacteria identified in Blood by Culture

3300

25195

1.45

62.26

4.5

4.3

—

(3000850) Epithelial cells [#/volume] in Urine

2670

19625

1.48

61.21

2.7

2.6

5.47

5.67

e6/l

0.21

2401

17552

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1559

10217

1.61

60.27

1.9

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

3153

24070

1.44

58.77

5.2

4.2

0.01

0.00

estimate

0.56

994

8003

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

204

594

3.48

58.15

1.1

1.0

281.70

290.29

mg/l

0.96

186

535

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2222

15878

1.50

58.11

3.1

2.8

1.23

1.35

e6/l

0.25

1296

9090

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6209

53266

1.39

58.01

3.1

2.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9481

88124

1.61

56.28

5.0

4.5

4.56

4.65

mmol/l

14.84

8734

81206

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9411

87456

1.58

54.34

4.9

4.4

1.45

1.48

mmol/l

10.87

8603

80134

(4200892) Spirometry reversibility

1082

6658

1.69

53.13

1.5

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3116

24124

1.41

52.37

2.6

2.7

2159.77

4835.21

umol/l

6.02

2664

20942

(40761535) Cells panel - Urine sediment

1205

7653

1.65

52.36

4.1

3.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2444

18124

1.45

52.10

4.3

3.8

288.76

469.41

ng/l

1.32

1867

14378

(3011288) Drugs identified in Urine by Screen method

373

1598

2.38

51.94

3.1

2.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1687

11621

1.54

51.79

8.8

7.2

—

(36660697) Celiac disease serology panel - Serum

1095

6824

1.67

51.15

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4180

34105

1.37

50.70

4.9

4.0

—

(40758558) Short blood count panel - Blood

2987

23083

1.41

50.32

6.5

6.9

—

(3001186) Copper [Moles/volume] in Serum or Plasma

182

5.37

49.04

1.1

1.3

16.50

17.02

umol/l

0.42

166

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9112

84478

1.50

48.95

4.4

4.0

1.32

1.29

mmol/l

3.94

8242

76722

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

232

812

2.90

48.64

1.1

83.38

83.60

au/ml

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1033

6453

1.66

47.66

2.0

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1706

11992

1.50

47.17

5.1

5.8

1.03

1.04

mmol/l

0.79

1569

11144

(1001926) Buprenorphine [Presence] in Urine by Screen method

403

1869

2.20

46.53

2.4

2.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1195

7808

1.60

45.90

2.0

2.6

67.03

66.27

g/l

3.27

1072

7062

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

176

543

3.28

45.85

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

2983

23354

1.38

45.57

4.0

89.75

89.26

0.45

2891

22770

(3016879) Cocaine [Presence] in Urine

451

2236

2.06

43.79

2.4

2.0

—

(3009508) Creatinine [Moles/volume] in Urine

3571

28940

1.35

43.28

3.3

3.2

7.36

7.31

mmol/l

0.26

2964

24191

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

894

5518

1.68

43.02

1.8

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

182

596

3.09

42.96

1.2

36.55

41.08

mg/l

0.70

151

503

(3003396) Base excess in Arterial blood by calculation

1518

10630

1.50

42.35

5.9

7.1

1.34

1.10

mmol/l

1.50

1239

8446

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1089

7103

1.59

41.94

3.5

3.8

86.87

91.04

ng/l

0.78

938

6081

(3000764) Benzodiazepines [Presence] in Urine

470

2403

2.00

41.91

2.4

2.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1518

10661

1.49

41.69

5.9

7.0

5.15

5.08

kpa

1.88

1452

10169

(3027945) Reticulocytes/100 erythrocytes in Blood

1514

10631

1.49

41.61

2.4

2.5

1.72

1.78

1.88

1278

9406

(3027801) Oxygen [Partial pressure] in Arterial blood

1517

10658

1.49

41.58

5.9

7.0

11.60

12.32

kpa

7.19

1443

10160

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

175

576

3.07

40.96

1.1

242.20

271.87

mg/l

1.07

152

502

(3028300) Cannabinoids [Presence] in Urine

470

2427

1.98

40.73

2.4

2.0

—

(3027008) Opiates [Presence] in Urine

469

2422

1.98

40.64

2.4

1.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

892

5582

1.65

40.62

3.1

3.3

4.41

4.43

pmol/l

0.21

755

4915

(3023410) Appearance of Cerebral spinal fluid

214

792

2.74

40.46

1.4

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

159

500

3.21

40.20

1.1

4.81

9.04

nmol/l

0.36

107

(3019225) pH of Specimen

1374

9535

1.51

39.87

4.5

4.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

614

3496

1.80

39.32

1.2

1.3

0.95

1.09

u/ml

0.10

318

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

199

728

2.77

38.49

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1926

14366

1.41

38.11

1.9

2.1

29.64

29.89

1.07

1864

13924

(3019060) Gas panel - Arterial blood

954

6169

1.60

37.94

4.1

4.9

—

(3016502) Oxygen saturation in Arterial blood

1367

9567

1.49

37.93

6.2

7.4

95.42

95.62

0.59

1316

9213

(3027944) Amphetamines [Presence] in Urine

454

2379

1.95

37.69

2.4

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

223

877

2.58

37.39

1.3

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

8321

76858

1.36

37.25

21.2

17.7

15.28

15.11

1.10

8216

75475

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

569

3218

1.81

37.24

2.0

2.3

275.94

643.93

ug/l

3.54

531

3028

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

911

5858

1.61

37.06

3.7

3.6

5.22

5.16

kpa

1.66

863

5547

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4989

43016

1.30

36.95

2.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

143

447

3.23

36.55

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

122

5.60

36.15

2.0

1.9

16.05

16.74

umol/l

0.17

122

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

202

4.43

36.05

1.2

96.53

133.66

nmol/l

1.60

154

(3000494) Fungus identified in Specimen by Culture

1477

10605

1.45

35.81

1.5

1.4

—

(3009343) pH of Capillary blood

896

5786

1.60

35.77

3.7

3.6

7.42

0.32

121

736

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1031

6877

1.55

35.75

1.7

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

366

1813

2.05

35.62

2.4

2.7

31.34

34.30

umol/l

1.85

336

1635

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1951

14743

1.39

35.50

3.4

3.0

3.22

2.73

e6/l

1.05

1035

8029

(3000570) Elastase.pancreatic [Mass/mass] in Stool

498

2745

1.85

35.41

1.4

283.53

270.13

ug/g

0.80

305

1608

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

868

5576

1.61

35.40

3.7

3.6

1.98

1.87

mmol/l

0.38

653

4157

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1235

8580

1.50

35.37

2.5

2.4

31.55

43.56

u/l

1.43

1035

7352

(3044640) Blood type and Crossmatch panel - Blood

3555

29433

1.31

35.20

2.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

165

581

2.87

34.32

1.0

788.42

715.69

ng/l

1.03

110

396

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

164

578

2.87

34.06

1.0

269.89

337.47

ng/l

3.45

115

404

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

165

584

2.85

34.00

1.0

39.38

44.57

ng/l

0.61

111

402

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

834

5373

1.60

33.56

1.6

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

653

3955

1.69

33.55

1.2

1.1

351.19

193.90

titre

0.50

(3014111) Lactate [Moles/volume] in Serum or Plasma

1159

8058

1.49

32.94

6.0

6.8

1.34

1.35

mmol/l

0.09

1130

7845

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1243

8766

1.47

32.89

6.4

7.8

122.13

120.73

g/l

1.66

1207

8533

(40768804) Tissue Pathology biopsy report

4378

37532

1.28

32.33

2.2

2.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1168

8166

1.48

32.25

2.6

2.4

5.20

7.08

ug/l

4.89

972

7075

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

459

2544

1.84

32.06

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

870

5724

1.57

31.94

1.3

1.2

105.56

146.57

iu/ml

2.40

324

2113

(3003327) Ova and parasites identified in Stool by Light microscopy

502

2874

1.78

31.50

1.8

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

460

2567

1.83

31.43

1.2

—

(3021589) Normoblasts [#/volume] in Blood

4604

39833

1.27

31.15

10.1

9.8

0.00

e9/l

0.38

3704

32515

(3017446) Testosterone [Moles/volume] in Serum or Plasma

855

5635

1.56

31.13

2.7

2.1

12.56

12.14

nmol/l

0.71

757

4972

(3000492) Spirometry study

1187

8382

1.47

31.10

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

460

2578

1.82

31.00

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2762

22395

1.31

30.98

2.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

878

5828

1.55

30.96

6.5

7.1

24.99

24.56

mmol/l

2.98

842

5554

(3026782) Osmolality of Urine

2360

18718

1.33

30.94

3.0

527.80

537.45

mosm/kgh2o

1.38

1983

16036

(3021387) Prolactin [Units/volume] in Serum or Plasma

442

2476

1.82

29.83

1.8

1.6

288.90

304.02

mu/l

0.48

402

2239

(3005322) IgE [Units/volume] in Serum or Plasma

803

5283

1.56

29.42

1.3

141.96

228.65

u/ml

5.61

744

4846

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

592

3628

1.67

29.05

4.1

3.9

25.05

24.89

mmol/l

0.69

551

3317

(3012516) Albumin [Mass/volume] in Urine

3286

27477

1.28

28.67

3.3

3.2

657.02

397.83

mg/l

1.64

2057

17270

(3023520) Reticulocytes [#/volume] in Blood

1129

8029

1.45

28.37

2.4

2.5

69.00

69.65

e9/l

0.24

853

6068

(3022313) Gas panel - Capillary blood

660

4190

1.61

28.13

3.9

3.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

970

6709

1.49

28.09

2.4

2.7

10.27

10.51

g/l

1.04

885

6142

(3020891) Body temperature

597

3702

1.65

27.97

5.1

4.8

—

(3013512) EKG study

3249

27239

1.28

27.48

4.4

4.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

881

6005

1.51

27.37

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

244

3.63

27.21

3.3

2.3

134.87

146.37

nmol/l

0.51

210

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

671

4327

1.59

26.77

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1449

10878

1.38

26.69

1.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

538

3293

1.67

26.51

3.9

4.1

1.34

1.40

mmol/l

0.60

533

3240

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1407

10538

1.39

26.26

2.5

2.7

6.19

8.53

umol/l

9.42

1166

9125

(3000991) Gas panel - Venous blood

1080

7731

1.44

26.11

7.3

8.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1822

14224

1.34

26.04

1.6

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

162

4.22

25.98

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

294

1512

1.97

25.83

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

462

2737

1.72

25.72

1.5

1.8

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

361

1991

1.84

25.65

2.0

1.7

41.42

42.26

nmol/l

0.29

348

1917

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

293

3.30

25.63

1.6

2.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

484

2911

1.69

25.49

1.7

3.23

3.83

mg/l

0.88

405

2139

(3022145) Colonoscopy Study observation

1371

10289

1.38

25.21

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

553

3476

1.62

24.53

1.1

2.20

1.61

u/ml

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

524

3252

1.64

24.46

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

350

1956

1.82

23.84

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

350

1956

1.82

23.84

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

276

1431

1.95

23.72

2.2

1.9

184.09

196.58

pmol/l

1.03

263

1336

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

541

3417

1.61

23.53

2.2

2.3

2.83

2.96

g/l

2.59

481

3046

(3023323) Follitropin [Units/volume] in Serum or Plasma

540

3433

1.60

22.86

1.4

1.3

28.15

30.38

iu/l

0.79

461

2938

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

582

3769

1.58

22.78

1.8

1.9

39.01

39.19

u/l

0.09

515

3299

(3051339) Copper [Moles/volume] in Blood

8.13

22.60

1.2

1.1

15.76

16.88

umol/l

1.03

(3036180) Methadone [Presence] in Urine

292

3.13

22.44

2.3

2.5

—

(3025941) Bacteria identified in Stool by Culture

730

4984

1.50

22.41

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

115

421

2.75

22.40

1.1

1.04

1.09

u/l

0.63

199

(3020682) Albumin/Creatinine [Ratio] in Urine

3374

28938

1.24

22.31

3.9

3.8

8.36

9.40

mg/mmol

0.58

2066

17991

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

743

5097

1.49

22.28

2.5

2.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

531

3405

1.59

21.68

2.2

2.3

9.93

10.20

g/l

0.76

466

3003

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

100

346

2.91

21.64

1.3

1.7

29.75

30.11

umol/l

0.13

336

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

563

3663

1.57

21.59

2.2

7.18

7.46

g/l

3.65

502

3288

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

562

3656

1.57

21.56

2.2

3.58

3.69

g/l

1.38

503

3283

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

441

2709

1.65

21.44

1.7

1.19

1.18

g/l

0.30

417

2552

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

430

2626

1.66

21.39

1.7

0.23

g/l

0.63

402

2473

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

561

3659

1.56

21.28

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

619

4128

1.53

21.24

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

383

2276

1.71

21.11

1.1

2.82

8.30

u/ml

2.59

259

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

129

516

2.52

21.08

1.4

1.5

5.26

6.39

u/l

1.60

107

429

(3017732) Neutrophils [#/volume] in Blood

877

6279

1.43

21.03

2.8

3.0

4.79

5.10

e9/l

0.27

661

4987

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3171

27176

1.24

20.77

5.3

5.1

2.39

3.44

ug/l

3.14

2814

24298

(3012544) pH of Venous blood

1171

8833

1.37

20.62

4.1

3.9

7.40

7.37

1.18

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

438

2715

1.64

20.56

2.2

0.01

0.04

g/l

1.80

399

2465

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1134

8527

1.37

20.36

4.2

3.9

5.90

5.83

kpa

1.57

1098

8286

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

642

4355

1.50

20.32

4.1

4.3

24.50

24.16

mmol/l

1.94

627

4268

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

145

3.95

20.02

1.0

—

(3002032) Base excess in Venous blood by calculation

1129

8506

1.37

20.00

4.2

3.9

2.02

1.93

mmol/l

0.38

992

7207

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

484

3097

1.59

19.95

2.2

2.4

0.58

0.91

g/l

1.51

418

2645

(3042936) Bacteria identified in Isolate by Culture

1638

13032

1.30

19.93

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1693

13551

1.30

19.66

1.9

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1461

11470

1.32

19.58

5.1

4.6

33.11

32.74

0.61

1012

7755

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

447

2826

1.61

19.38

2.2

38.83

37.53

g/l

5.14

382

2446

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

403

2484

1.65

19.36

2.3

0.00

g/l

-0.00

368

2278

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

148

656

2.27

19.28

1.2

1.3

2.01

2.10

mmol/l

0.53

139

612

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1375

10734

1.32

19.16

3.3

4.2

237.34

245.63

u/l

1.19

1264

10106

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2806

23920

1.23

18.97

1.7

1.6

1.37

1.36

mmol/l

0.34

2372

19931

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

407

2529

1.63

18.94

2.3

0.00

g/l

0.44

370

2287

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

406

2528

1.63

18.74

1.3

39.56

41.31

u/ml

0.04

157

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2560

21683

1.24

18.26

4.7

4.5

21.96

21.91

0.05

1209

10960

(3003338) MCHC [Mass/volume]

7920

74761

1.22

17.92

25.3

19.2

331.77

331.93

g/l

0.88

7873

74198

(3020779) Urea [Moles/volume] in Serum or Plasma

1087

8286

1.35

17.77

6.3

7.2

9.65

10.10

mmol/l

1.30

1020

7888

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

166

804

2.08

17.37

1.4

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

578

3966

1.48

17.29

1.2

1.6

19.31

13.49

u/ml

—

113

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

233

1271

1.85

17.27

1.3

0.61

1.86

nmol/l

0.72

224

1226

(3009214) Lutropin [Units/volume] in Serum or Plasma

336

2037

1.67

17.25

1.4

1.3

10.60

11.08

u/l

0.25

267

1652

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

233

1275

1.85

17.10

1.3

0.41

0.18

nmol/l

0.69

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

307

1831

1.70

16.77

1.2

1.3

42.71

42.09

u/ml

0.02

192

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1070

8207

1.34

16.74

2.9

182.30

201.48

ng/l

0.98

982

7507

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

350

2165

1.64

16.62

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

215

1158

1.87

16.60

1.3

—

(3049717) Cytology report of Urine Cyto stain

520

3524

1.50

16.54

2.5

2.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

220

1197

1.86

16.46

1.5

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

927

6996

1.36

16.13

3.5

3.3

4.58

4.54

kpa

0.26

892

6769

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

458

2.39

16.13

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

371

2347

1.60

16.09

1.3

6.61

6.71

u/ml

0.02

378

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

592

4146

1.45

15.95

1.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

171

867

1.99

15.82

1.6

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

364

2323

1.59

15.23

1.3

12.76

4.21

u/ml

0.49

251

(4034850) Laboratory test

433

2879

1.52

15.10

11.9

10.2

—

(3042517) Benzodiazepines panel - Urine

5.38

14.92

2.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

440

2.35

14.73

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

11.33

14.23

1.1

0.35

0.25

umol/24h

0.43

(3052851) Hemolysis interference index of Serum or Plasma

427

2875

1.51

14.05

3.3

3.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

472

3262

1.47

13.65

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

210

1196

1.77

13.60

2.0

2.1

18.60

26.79

mg/l

1.72

304

(4094501) Cardiovascular stress test using bicycle ergometer

359

2348

1.55

13.54

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

326

2087

1.58

13.51

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

707

5258

1.37

13.49

1.8

1.9

1.37

1.36

g/l

0.02

637

4770

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

351

2289

1.55

13.41

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

341

2212

1.56

13.34

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

423

2.30

13.28

1.5

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

604

4389

1.40

13.27

1.6

1.7

1.51

1.57

g/l

0.77

509

3760

(3035637) Corticotropin [Mass/volume] in Plasma

198

1119

1.78

13.18

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

955

7455

1.31

13.11

2.3

2.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

128

630

2.04

12.95

1.5

1.4

1.27

1.30

promille

0.07

484

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

451

3122

1.46

12.95

1.5

1.6

157.50

318.88

titre

1.61

143

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

868

6707

1.32

12.82

2.2

1.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1096

8740

1.28

12.77

2.2

0.22

0.21

g/l

4.48

1023

8131

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

510

3627

1.43

12.68

2.0

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

549

3957

1.41

12.66

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

458

3208

1.45

12.38

2.6

2.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

658

4906

1.36

12.36

7.4

8.9

24.58

24.36

mmol/l

0.96

627

4750

(3017143) Hepatitis C virus Ab [Presence] in Serum

1153

9331

1.26

11.88

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

936

7389

1.29

11.79

2.5

2.6

64.38

64.43

ml/min/173m2

0.01

382

2979

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

400

2759

1.47

11.73

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

115

569

2.03

11.53

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2679

23647

1.18

11.37

4.0

3.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

308

2.41

11.32

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

334

2.35

11.21

1.1

2624.06

400.71

ng/l

0.53

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.91

11.19

4.7

10.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

251

2.56

11.11

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

369

2541

1.47

10.94

1.4

21.06

14.41

iu/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1182

9701

1.25

10.74

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

112

567

1.99

10.57

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

293

1940

1.52

10.54

1.2

2.34

4.39

u/ml

0.58

147

(3006184) Hemoglobin [Mass/volume] in Capillary blood

318

2145

1.50

10.47

2.0

2.2

131.04

128.50

g/l

0.99

228

1529

(3015235) Bicarbonate [Moles/volume] in Capillary blood

345

2379

1.47

10.18

2.7

3.1

25.27

24.87

mmol/l

1.11

340

2328

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1803

15521

1.19

10.11

3.3

3.1

0.71

0.78

ug/l

1.43

1258

10649

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

713

5541

1.31

10.11

6.5

7.0

25.13

24.84

mmol/l

1.31

704

5502

(3047181) Lactate [Moles/volume] in Blood

411

2936

1.42

10.03

4.7

6.1

1.27

1.31

mmol/l

0.35

368

2604

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

199

1224

1.64

9.85

1.1

5.78

11.59

au/ml

—

(3008898) HLA-B27 [Presence]

379

2679

1.43

9.82

1.1

—

(3014271) Vancomycin [Susceptibility]

468

2.04

9.71

3.1

2.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

429

2.08

9.65

2.5

2.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

288

1938

1.50

9.63

1.3

1.2

6.06

18.36

u/ml

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

200

1243

1.62

9.51

1.5

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

225

2.50

9.31

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

221

2.50

9.15

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

550

4187

1.33

9.06

2.0

1.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

223

2.47

8.99

1.0

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

469

1.99

8.95

1.2

203.15

288.59

u/l

1.07

430

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

317

2.22

8.92

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

224

2.46

8.91

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.46

8.89

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

179

1105

1.63

8.78

1.1

2.69

3.57

u/ml

0.38

479

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

221

1439

1.55

8.66

1.2

1.4

—

(3037121) Protein [Mass/volume] in Urine

434

3218

1.36

8.53

2.9

3.1

0.29

0.33

g/l

0.49

154

1319

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

192

1215

1.59

8.52

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

193

1223

1.59

8.52

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

465

1.97

8.46

1.1

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

108

588

1.85

8.30

1.2

1.3

1.47

1.50

u/ml

0.02

330

(3023419) Bacteria identified in Sputum by Culture

212

1382

1.54

8.28

2.8

2.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

198

1271

1.57

8.28

1.1

48021.75

739.30

iu/ml

0.48

298

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

313

2209

1.43

8.25

1.7

1.8

71.11

4.59

iu/l

0.80

778

(3000093) Morphology [Interpretation] in Blood Narrative

146

870

1.69

8.24

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

157

2.68

8.12

1.3

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

216

1429

1.52

7.91

1.6

0.65

0.78

g/l

1.33

168

1072

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

208

2.41

7.79

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

369

2.04

7.78

3.4

2.0

149.07

131.14

umol/l

0.19

202

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

252

2.27

7.74

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

189

1221

1.56

7.72

1.5

1.4

70.70

58.57

mu/l

0.41

172

1085

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

409

3061

1.35

7.61

2.5

3.3

35.81

48.13

mg/l

1.23

338

2479

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

219

1468

1.50

7.56

1.2

1.3

38.16

37.77

u/l

0.01

184

1276

(3003181) Sodium [Moles/volume] in Urine

245

1680

1.47

7.56

1.3

1.4

64.47

63.29

mmol/l

0.17

198

1340

(3010838) Calcium [Moles/time] in 24 hour Urine

240

1642

1.47

7.49

1.9

4.59

4.99

mmol/24h

1.31

213

1435

(3024928) Oxygen saturation in Venous blood

272

1908

1.44

7.45

3.1

3.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

187

1216

1.55

7.44

1.4

—

(21494755) Public health laboratory ask at order entry panel

553

6996

0.78

7.40

1.4

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

407

3060

1.34

7.36

2.5

3.3

54.11

73.06

mg/l

0.42

336

2475

(4146454) Self-monitoring of blood glucose

162

1022

1.59

7.35

2.5

2.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

765

6246

1.24

7.28

1.7

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

397

2980

1.34

7.26

2.5

3.2

2.14

3.08

ratio

0.38

235

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

143

879

1.64

7.22

3.9

3.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

177

1145

1.55

7.22

1.3

309.61

326.39

pmol/l

0.19

159

970

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

329

2400

1.38

7.22

1.9

2.0

10.74

11.73

mg/l

1.32

305

2211

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

186

1217

1.54

7.21

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

186

1220

1.53

7.13

1.5

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

938

7843

1.21

7.10

3.7

3.9

1.23

mmol/l

0.63

790

6824

(3039162) Centromere protein B Ab [Units/volume] in Serum

175

1134

1.55

7.09

1.2

1.3

38.38

61.77

u/ml

0.70

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

213

1441

1.49

7.06

1.2

1.1

1.90

2.02

u/ml

0.06

109

711

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1343

11622

1.18

6.94

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

456

1.87

6.92

1.4

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

176

1150

1.54

6.89

1.2

—

(3036489) Thrombin time

430

3294

1.32

6.86

1.6

2.1

21.33

21.47

0.16

378

2887

(40761536) Microorganisms panel - Urine sediment

921

7720

1.21

6.80

4.6

4.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

144

901

1.61

6.80

1.5

1.4

6.11

6.70

g/l

1.68

107

621

(3024139) IgG subclass 3 [Mass/volume] in Serum

144

901

1.61

6.80

1.5

1.4

0.38

0.42

g/l

0.81

107

622

(3028192) IgG subclass 2 [Mass/volume] in Serum

144

902

1.60

6.77

1.5

1.4

2.87

2.90

g/l

0.07

106

623

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.02

6.75

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

326

2405

1.37

6.70

2.5

2.1

4255.62

4765.75

u/l

0.13

113

953

(3044927) Protein electrophoresis panel - Urine

155

992

1.57

6.66

1.1

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.71

6.62

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

165

1073

1.55

6.61

10.7

12.9

7.57

7.32

mmol/l

0.42

135

891

(3004119) Hemoglobin [Mass/volume] in Venous blood

684

5586

1.24

6.52

3.5

128.77

128.45

g/l

0.14

671

5454

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

335

2494

1.35

6.51

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

308

2267

1.37

6.44

1.6

11244.26

13754.20

e6/l

0.63

230

1624

(3007566) Smooth muscle Ab [Titer] in Serum

327

2430

1.36

6.43

1.2

93.33

135.43

titre

0.56

221

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

327

1.99

6.42

1.4

1.5

14.41

16.08

pmol/l

1.44

267

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

7.38

6.40

1.4

1.7

129.75

221.21

nmol/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.97

6.36

1.0

—

(3021901) Oxygen saturation in Capillary blood

241

1706

1.42

6.35

2.6

2.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

371

1.92

6.30

1.2

152.54

158.46

mmol/24h

0.27

371

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.58

6.30

1.1

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

622

5050

1.25

6.26

7.9

9.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

482

3801

1.28

6.21

2.0

1.9

1.76

2.29

ug/l

0.59

405

3346

(4062490) Immunoglobulin typing, IgG

141

900

1.57

6.17

1.5

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

176

1182

1.50

6.11

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.75

6.07

1.0

1.6

42.25

36.12

0.19

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.88

6.03

2.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

500

1.77

6.01

2.4

2.2

16.04

34.71

umol/l

—

(3010421) pH of Blood

325

2440

1.34

6.01

4.0

4.1

7.42

0.52

296

2218

(3051593) INR in Capillary blood by Coagulation assay

449

1.81

6.01

7.5

11.9

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

106

637

1.67

5.93

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

451

1.80

5.92

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

106

638

1.67

5.89

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

504

1.75

5.86

1.4

157.72

180.39

pmol/l

0.49

504

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

105

632

1.67

5.84

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

513

1.74

5.80

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

515

4134

1.26

5.76

4.0

4.1

51.28

48.13

2.23

509

4087

(3012501) Base excess in Blood by calculation

283

2097

1.36

5.72

3.9

4.1

2.56

2.55

mmol/l

0.01

196

1436

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.34

5.71

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

266

2.04

5.70

1.2

106.69

112.26

0.90

231

(3013290) Carbon dioxide [Partial pressure] in Blood

283

2099

1.36

5.69

3.9

4.1

5.10

4.99

kpa

1.93

275

2061

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

5.17

5.69

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

195

1357

1.45

5.68

1.5

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

105

637

1.65

5.68

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.09

5.68

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

173

2502

0.69

5.67

5.1

4.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

287

1.99

5.67

1.2

0.32

0.31

g/l

0.28

231

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

104

632

1.65

5.60

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

145

954

1.53

5.59

1.6

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

284

2114

1.35

5.59

3.9

4.2

8.81

8.57

kpa

1.38

276

2076

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

162

1092

1.49

5.56

1.4

0.30

0.37

nmol/l

0.83

128

824

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.81

5.53

1.0

1.7

7.27

16.84

1.30

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

521

1.71

5.51

1.1

12.15

9.67

iu/ml

0.12

129

(3004616) Nuclear Ab [Presence] in Serum

168

1145

1.47

5.47

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

547

4449

1.24

5.46

4.0

3.5

25.32

25.18

mmol/l

0.44

531

4323

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1100

9550

1.17

5.45

3.8

3.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

299

1.94

5.41

2.7

2.9

24.61

28.50

umol/l

1.30

228

(40759836) Histone Ab [Presence] in Serum by Immunoblot

103

631

1.64

5.39

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

186

1297

1.44

5.39

1.1

6.09

5.20

u/ml

0.24

650

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

210

1497

1.41

5.39

1.4

113.86

116.65

u/ml

0.13

315

(3017181) Myelocytes/100 leukocytes in Blood

922

7900

1.18

5.37

3.6

4.1

0.93

0.95

0.07

301

2794

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

169

1158

1.47

5.37

1.3

30.57

29.15

u/l

0.18

130

946

(3003577) Lead [Moles/volume] in Blood

3.55

5.31

1.1

1.3

0.08

0.13

umol/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

490

1.72

5.29

1.6

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

288

1.95

5.27

1.5

1.4

82.83

231.13

nmol/24h

1.41

288

(3020717) Zinc [Moles/volume] in Serum or Plasma

439

1.76

5.25

1.3

1.5

23.80

24.55

umol/l

0.08

417

(3010726) Horse dander IgE Ab [Units/volume] in Serum

168

1156

1.46

5.23

1.1

1.99

1.40

u/ml

0.50

563

(3045424) Erythrocytes [Presence] in Urine

215

1549

1.40

5.20

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

207

1482

1.40

5.20

1.6

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

136

899

1.52

5.16

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1545

13804

1.14

5.14

1.5

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

103

2.63

5.13

2.1

2.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

139

925

1.51

5.12

1.1

5.57

3.36

u/ml

0.52

359

(3021440) Promyelocytes/100 leukocytes in Blood

876

7507

1.18

5.10

3.7

4.1

0.17

0.11

1.00

258

2405

(40768443) Skin Pathology biopsy report

520

4244

1.24

5.06

1.2

—

(3008295) Osmolality of Serum or Plasma

142

952

1.50

5.05

1.5

1.4

282.94

278.12

mosm/kgh2o

1.53

105

726

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

136

904

1.51

5.04

2.8

3.0

—

(3025159) Blasts/100 leukocytes in Blood

832

7108

1.18

5.03

3.7

4.1

0.10

0.34

1.66

215

2032

(3022621) pH of Urine by Test strip

728

6147

1.20

5.03

3.7

3.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

210

1517

1.39

5.02

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

717

6048

1.20

5.01

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

195

1394

1.41

4.96

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

355

1.81

4.82

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

220

1615

1.37

4.79

2.0

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

227

1675

1.36

4.79

1.5

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

176

1246

1.42

4.75

1.1

0.85

1.19

u/ml

0.37

516

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

167

1172

1.43

4.73

1.1

1.47

1.53

g/l

1.53

150

1053

(3034770) Mitochondria Ab [Titer] in Serum

314

2435

1.30

4.71

1.2

630.00

906.94

titre

—

(1616796) Gas panel - Central venous blood

273

2077

1.32

4.70

3.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

120

2.42

4.70

1.2

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

145

993

1.47

4.68

1.1

5.01

3.11

u/ml

0.50

460

(3019420) Tryptase [Mass/volume] in Serum or Plasma

441

1.71

4.64

1.1

1.6

6.16

8.89

ug/l

1.54

393

(3002179) Metamyelocytes/100 leukocytes in Blood

836

7204

1.17

4.58

3.4

3.9

0.62

0.72

0.62

260

2422

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

413

1.72

4.57

1.7

1.6

6.36

4.66

nmol/l

0.23

340

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

363

1.77

4.50

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

195

1420

1.38

4.49

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

477

1.66

4.45

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

477

1.66

4.45

1.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

299

2323

1.30

4.44

2.3

3.4

—

(3039000) Anion gap in Blood

271

2079

1.31

4.42

5.5

7.1

11.00

11.23

mmol/l

0.44

241

1873

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

226

1689

1.35

4.42

1.2

—

(3018572) Chloride [Moles/volume] in Blood

271

2080

1.31

4.41

5.5

7.1

104.92

105.10

mmol/l

0.26

241

1874

(3001019) Free T4 and TSH panel - Serum or Plasma

480

3947

1.23

4.39

1.9

1.7

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.00

4.39

1.1

8.83

15.27

u/l

0.74

(3008116) Ketones [Moles/volume] in Urine by Test strip

176

2.11

4.36

1.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

317

2490

1.28

4.34

1.4

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

197

2.03

4.31

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

138

955

1.45

4.26

1.5

1.4

28.44

23.37

iu/ml

—

(3051651) Icteric interference index of Serum or Plasma

553

1.60

4.25

3.1

3.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.49

4.24

1.3

1.4

477.85

516.55

nmol/l

0.07

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

100

648

1.55

4.23

2.9

3.4

117.63

142.49

nmol/l

0.42

100

641

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

186

2.05

4.17

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

173

2.08

4.15

1.1

1.3

—

(44813793) Dust mix specific IgE antibody measurement

590

1.56

4.09

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

238

1.89

3.99

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.82

3.95

2.6

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

398

3255

1.23

3.88

2.7

3.1

0.36

0.35

u/ml

0.20

224

1862

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

314

2503

1.26

3.85

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

648

1.52

3.83

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

116

795

1.46

3.81

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

116

795

1.46

3.81

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

116

795

1.46

3.81

1.5

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

375

1.68

3.80

2.5

2.2

51.63

53.00

umol/l

0.16

322

(3032057) Clostridioides difficile [Presence] in Stool

214

1.92

3.80

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

145

1041

1.40

3.71

1.2

56.23

63.88

u/l

1.24

128

921

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

282

2231

1.27

3.70

2.1

2.2

103.48

96.80

ug/min

0.08

157

1294

(3051611) Lipemic interference index of Serum or Plasma

141

1008

1.40

3.70

3.3

3.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

105

711

1.48

3.67

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

473

1.59

3.63

1.5

1.3

1.10

1.21

nmol/l

0.37

363

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.42

3.62

2.0

1.7

38.41

44.09

umol/l

0.57

(3002256) Pathology report gross observation

1351

12235

1.12

3.60

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

221

1702

1.30

3.59

2.1

1.7

0.87

0.81

nmol/l

0.59

175

1426

(21494890) Protein electrophoresis panel - 24 hour Urine

136

973

1.40

3.56

1.7

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

279

2216

1.27

3.56

1.5

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

227

1.85

3.53

1.8

1.6

0.49

0.38

ug/l

0.83

139

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.16

3.50

2.0

—

(3021788) Differential panel - Synovial fluid

221

1710

1.30

3.48

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

663

1.48

3.47

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.42

3.46

1.1

1.2

1.67

1.64

umol/24h

0.07

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

134

964

1.39

3.42

1.5

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

2.30

3.42

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

122

865

1.42

3.39

1.7

2.0

8.73

7.62

umol/l

0.25

634

(3013005) Retinol [Moles/volume] in Serum or Plasma

350

1.66

3.37

1.6

1.8

1.77

2.00

umol/l

1.76

326

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

603

1.50

3.35

2.5

2.4

489.33

514.41

e6/l

0.22

499

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

588

1.50

3.32

1.2

1.4

13.13

12.54

umol/l

0.31

549

(3007463) Buprenorphine [Presence] in Urine

4.35

3.30

4.6

7.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

192

1469

1.31

3.30

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

192

1469

1.31

3.30

1.4

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

116

820

1.42

3.29

1.1

1.0

0.08

0.41

u/ml

1.45

232

(3010144) Erythrocytes [#/volume] in Synovial fluid

123

879

1.40

3.28

1.3

1.4

134057.21

150385.92

e6/l

0.10

595

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

353

1.65

3.27

1.1

1.3

4.82

4.17

umol/l

0.61

328

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

273

2191

1.25

3.23

1.5

1.6

—

(3019230) Fractional oxyhemoglobin in Venous blood

202

1563

1.30

3.21

3.3

3.1

64.24

63.68

0.14

202

1558

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

136

2.06

3.21

1.2

185.90

165.57

ng/l

0.07

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

235

1.79

3.19

1.0

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.53

3.19

1.0

1.6

5.86

1.25

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

387

1.61

3.17

1.1

2.13

6.27

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

198

1531

1.30

3.17

1.2

318.81

278.19

u/ml

0.66

123

957

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

181

1.88

3.04

1.1

1.3

0.62

99.34

mg/l

1.44

137

(3037756) Immunofixation for Serum or Plasma

254

2038

1.25

3.03

1.5

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

140

1038

1.35

3.02

2.8

4.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

505

1.51

2.99

1.1

18.45

26.81

u/l

1.39

453

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.75

2.98

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

251

2016

1.25

2.98

2.7

2.5

16.97

16.13

2.52

146

1047

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

166

1267

1.32

2.95

1.3

1.2

1.84

3.74

u/ml

3.00

412

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

580

1.47

2.94

2.6

2.4

0.24

0.22

e9/l

0.31

496

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

106

754

1.41

2.94

1.2

45.00

38.87

u/ml

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

507

1.50

2.94

1.1

70.79

85.04

u/l

1.97

455

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

696

1.43

2.93

1.3

8.58

8.80

mmol/l

0.19

669

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

205

1.81

2.93

1.0

10.49

12.18

u/ml

0.10

120

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

121

2.07

2.91

1.0

1.4

45.75

54.18

0.33

(3016038) Potassium [Moles/volume] in Urine

631

1.45

2.91

1.2

32.32

34.69

mmol/l

0.49

537

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

405

1.56

2.88

1.1

—

(3044941) Cell count panel - Synovial fluid

184

1429

1.29

2.88

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

115

2.09

2.87

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

603

6880

0.87

2.85

1.8

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

220

1751

1.26

2.84

2.8

3.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

315

2607

1.21

2.84

1.9

2.6

3.56

3.60

g/l

0.15

297

2469

(3016650) Hepatitis A virus Ab [Presence] in Serum

178

1381

1.29

2.82

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

480

1.50

2.81

1.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

133

991

1.35

2.80

1.3

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

133

991

1.35

2.80

1.3

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

160

1225

1.31

2.80

5.4

6.5

12.02

11.78

mg/l

0.34

142

1126

(3030981) Hyaline casts [#/volume] in Urine by Automated count

562

4894

1.16

2.80

3.1

2.8

0.31

0.30

e6/l

0.06

544

4773

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

228

1827

1.25

2.79

1.5

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

2.54

2.78

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

179

1397

1.29

2.72

1.1

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

155

1187

1.31

2.72

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

321

2675

1.21

2.71

1.7

2.3

92.70

91.41

0.48

311

2570

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

161

1240

1.30

2.71

1.3

1.2

4.06

4.27

u/ml

0.10

535

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.45

2.68

1.6

1.4

30.15

21.65

nmol/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

259

2115

1.23

2.68

1.5

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

135

1016

1.33

2.68

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

120

888

1.36

2.66

1.6

1.7

—

(3016330) Potassium [Moles/time] in 24 hour Urine

112

2.06

2.66

1.5

1.2

—

89.82

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

374

1.55

2.65

1.1

0.63

2.47

u/ml

0.56

101

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

205

1636

1.26

2.62

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

242

1972

1.23

2.57

3.6

3.1

0.86

0.83

nmol/l

0.41

192

1509

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

298

2481

1.21

2.56

1.9

2.5

188.57

195.32

0.62

282

2358

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

346

1.56

2.55

2.0

54.30

61.51

ug/l

0.48

335

(3014599) Egg white IgE Ab [Units/volume] in Serum

426

1.51

2.55

1.0

1.1

4.57

1.17

u/ml

0.40

108

(3005033) Fetal Nuchal fold Thickness US

1179

0.71

2.55

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

160

1246

1.29

2.51

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

216

1.72

2.51

1.0

1.2

759.10

300.86

pmol/l

0.39

157

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

115

2.00

2.50

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1183

0.72

2.46

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.46

2.44

1.0

0.04

0.74

u/ml

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.55

2.44

1.2

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

199

1600

1.25

2.41

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

188

1502

1.26

2.41

2.2

1.8

1.64

1.68

mmol/l

0.27

181

1473

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.35

2.38

1.1

—

(3006270) Folate [Moles/volume] in Blood

109

812

1.35

2.36

1.1

1.2

330.73

349.17

nmol/l

0.47

671

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

205

1.71

2.36

1.2

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.26

2.33

1.3

1.53

1.05

ml/s/173m2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

662

1.38

2.30

4.1

2.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

110

825

1.34

2.29

4.1

4.9

149.00

71.65

u/ml

0.53

238

(3013336) Amino acids [Identifier] in Serum or Plasma

4.62

2.27

1.2

4.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

120

1.92

2.24

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

439

1.46

2.24

1.1

12.32

1.83

u/ml

0.41

143

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

110

1447

0.76

2.23

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

283

2382

1.19

2.21

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

110

1445

0.76

2.21

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

121

1.90

2.20

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

107

1.96

2.19

3.2

2.6

0.57

0.55

u/field

0.04

107

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

617

1.38

2.19

1.4

1.3

86.67

69.81

titre

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

777

7029

1.11

2.19

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1226

0.74

2.19

1.4

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

409

1.47

2.18

1.1

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.07

2.16

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

111

1450

0.76

2.15

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

115

1.91

2.15

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

101

1.98

2.15

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

111

1449

0.76

2.14

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

354

1.50

2.13

2.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

412

1.46

2.11

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

259

1.59

2.11

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

639

1.36

2.10

1.5

7.14

7.20

u/l

0.01

514

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

589

1.38

2.08

1.2

69.46

86.25

u/l

1.32

506

(3020491) Glucose [Moles/volume] in Blood

658

1.36

2.07

2.1

1.9

6.70

6.84

mmol/l

0.26

456

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

124

1.86

2.06

1.1

1.0

106.88

78.05

ug/l

1.75

100

(1761868) Lipid panel - Serum or Plasma

2873

30015

0.94

2.06

3.0

2.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

157

1255

1.25

2.06

1.5

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

110

1.91

2.05

4.5

5.1

—

(3011412) CD3 cells [#/volume] in Blood

113

867

1.31

2.05

2.6

2.3

1.24

1.18

e9/l

0.38

105

773

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

442

3889

1.14

2.00

4.4

5.1

1.68

1.63

0.46

408

3653

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

637

1.35

1.99

1.4

1.3

272.86

284.58

titre

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

101

1319

0.76

1.98

1.4

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

225

2685

0.83

1.97

1.4

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

452

1.42

1.96

1.3

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

173

1407

1.23

1.96

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

331

2857

1.16

1.96

1.5

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

149

1193

1.25

1.94

1.8

2.1

32.23

32.70

0.67

149

1182

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

4.55

1.94

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.96

1.93

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.96

1.93

1.0

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

218

1.61

1.93

2.6

2.1

240.87

780.64

e6/l

0.76

109

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.45

1.92

7.9

4.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

730

1.32

1.88

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.18

1.88

1.1

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

291

2497

1.17

1.87

2.8

2.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

611

1.34

1.85

2.4

2.5

815.36

675.93

e6/l

1.51

584

(3003740) Influenza virus B Ag [Presence] in Specimen

147

1185

1.24

1.83

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

198

1.62

1.82

1.1

0.74

0.64

umol/24h

0.67

(4281824) Cell count and differential, peritoneal fluid

1087

0.75

1.82

1.2

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

4.17

1.82

1.8

1.3

143.60

105.80

nmol/l

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

313

2708

1.16

1.82

1.6

0.33

11.13

iu/ml

1.09

603

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

206

1.60

1.82

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.12

1.81

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

144

1160

1.24

1.81

1.5

1.6

52.64

58.61

0.92

733

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

571

1.35

1.80

1.2

15.67

22.58

u/l

1.49

477

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.79

1.6

1.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

125

1565

0.80

1.78

1.4

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

215

1.58

1.78

1.0

1.1

7.00

5.78

u/ml

0.07

112

(3028433) Virus identified in Specimen by Culture

320

1.47

1.77

1.3

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

582

1.34

1.76

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

433

3844

1.13

1.75

4.4

5.2

0.90

0.88

0.55

399

3613

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

193

1.61

1.74

2.0

1.6

121.37

121.87

ng/l

0.00

193

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.22

1.73

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

273

1.50

1.73

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

187

1.61

1.68

1.2

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

349

1.43

1.68

1.1

1789.08

1534.47

miu/ml

0.75

349

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

450

1.38

1.67

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

450

1.38

1.67

1.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

145

1183

1.23

1.65

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

132

1066

1.24

1.65

1.1

—

(3019977) pH of Arterial blood

546

1.34

1.64

2.2

2.8

7.44

7.42

0.95

194

(3041354) Potassium [Moles/volume] in Venous blood

1203

0.78

1.64

2.7

2.3

4.05

4.07

mmol/l

0.11

1191

(3035285) Chloride [Moles/volume] in Venous blood

1203

0.78

1.64

2.7

2.3

106.44

105.59

mmol/l

1.10

1191

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

269

1.49

1.62

1.2

1.1

90.50

87.76

0.18

124

(3012565) Volume of 24 hour Urine

470

1.36

1.62

2.0

2.2

2050.49

1908.79

0.43

415

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.91

1.59

1.1

2.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

404

1.39

1.58

1.2

1.1

9.89

20.37

u/ml

—

(3004451) EKG impression Narrative

455

1.36

1.58

1.4

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.20

1.56

1.4

1.5

415.55

328.20

umol/24h

0.76

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

188

1583

1.19

1.56

1.6

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

145

1191

1.22

1.56

1.1

120.76

117.03

0.63

136

1061

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

114

1.76

1.56

1.6

1.3

0.25

0.29

nmol/l

0.17

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

235

2022

1.17

1.52

1.6

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

494

1.34

1.50

1.1

1.2

1.06

ratio

0.08

167

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

607

1.30

1.50

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

112

900

1.25

1.49

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

411

4582

0.89

1.48

1.5

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

307

2701

1.14

1.47

1.9

1.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

726

1.27

1.44

1.1

1.2

86.00

175.19

titre

1.93

133

(3006567) Chloride [Moles/time] in 24 hour Urine

3.13

1.44

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

236

1.48

1.43

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

236

1.48

1.43

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

236

1.48

1.43

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

236

1.48

1.43

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.97

1.43

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1179

0.80

1.43

2.7

2.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

534

1.31

1.42

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

278

1.44

1.41

2.8

2.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

262

1.45

1.40

1.2

84.53

88.39

0.25

125

(37021550) Renin [Units/volume] in Plasma --upright

205

1.51

1.39

1.1

1.3

87.74

78.53

mu/l

0.08

150

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

173

1.56

1.39

1.1

1.2

89.14

79.48

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

173

1.56

1.39

1.2

67.14

75.70

—

(40762814) Titanium [Mass/volume] in Blood

174

1.55

1.36

2.1

2.2

3.53

3.93

ug/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.83

1.35

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

161

0.50

1.35

4.0

2.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.75

1.34

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

689

1.26

1.34

1.4

1.5

11.80

12.78

u/l

0.82

661

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.91

1.33

1.7

1.3

21.83

21.87

mmol/l

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

105

1.72

1.32

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.78

1.32

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

532

1.30

1.31

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.50

1.30

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

147

1237

1.19

1.29

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

276

1.41

1.28

1.2

1.1

—

(3048879) Bone marrow aspiration report

276

1.41

1.28

1.3

1.7

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.08

1.27

1.3

1.2

—

2.04

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.05

1.26

1.0

0.87

3.41

u/ml

—

(3020650) Glucose [Presence] in Urine

219

1.46

1.25

1.3

1.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.40

1.24

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.40

1.24

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

118

0.42

1.24

3.8

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

118

0.42

1.24

7.6

5.9

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.00

1.23

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

468

1.31

1.22

4.0

3.8

—

(40768806) Pleura Pathology biopsy report

1043

0.80

1.21

1.6

—

(3003694) ABO and Rh group [Type] in Blood

2494

24087

1.05

1.21

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

120

1000

1.20

1.19

2.5

3.4

60.53

57.29

1.07

101

848

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.31

1.18

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.75

1.18

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

109

1.65

1.18

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

489

1.29

1.17

2.1

1.9

1.89

2.78

u/field

0.57

335

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.70

1.17

2.4

1.9

0.48

1.08

mmol/l

1.34

(3017704) Immunofixation for Urine

534

1.28

1.16

1.3

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

632

1.25

1.16

2.5

2.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

182

1.48

1.15

1.5

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

367

0.68

1.13

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

153

1780

0.86

1.12

1.3

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

157

1350

1.17

1.10

2.8

2.5

144.43

1664.82

u/ml

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

808

1.21

1.10

1.5

1.3

1.47

nmol/l

0.00

722

(4035726) Immunohistochemistry procedure

792

8437

0.93

1.10

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.95

1.08

1.0

9.14

8.42

mmol/l

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

144

1.53

1.08

1.1

48.61

55.92

u/ml

0.22

137

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

120

1.58

1.08

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

120

1.58

1.08

1.7

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

120

1.58

1.08

1.0

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

235

1.41

1.08

1.8

1.9

8.51

9.32

mg/l

0.44

191

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

356

1.32

1.06

3.0

2.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

257

2297

1.12

1.04

1.4

1.3

262.74

221.69

miu/ml

0.96

109

1041

(3015183) Erythrocyte sedimentation rate

385

1.30

1.02

1.2

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

438

1.28

1.01

1.5

1.40

4.23

—

103

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.89

1.01

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

483

1.26

1.01

1.7

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

736

1.21

1.00

1.5

1.6

24.92

23.08

u/ml

0.11

151

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

102

856

1.19

0.98

2.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

485

1.26

0.98

1.7

1.8

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.17

0.98

5.0

8.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

266

1.35

0.97

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.97

0.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

980

0.83

0.96

1.3

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

100

1.60

0.96

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

118

1007

1.17

0.95

1.5

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

364

0.71

0.94

1.3

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

143

1240

1.16

0.94

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

705

1.21

0.94

1.8

1.5

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.89

0.94

1.0

1.1

—

24.24

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

199

1770

1.13

0.91

5.5

5.2

1550.53

2058.03

iu/ml

0.15

253

(3006442) Creatine [Moles/volume] in Serum or Plasma

581

1.22

0.90

1.9

1.5

79.79

82.76

umol/l

0.39

581

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.63

0.84

1.1

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

104

891

1.17

0.83

1.2

1.1

96.10

95.42

0.11

832

(3011648) Oxygen content in Venous blood

717

1.19

0.81

2.0

2.6

11.02

10.89

0.09

717

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

444

1.24

0.81

2.7

3.5

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

4.3

—

4.73

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

439

1.23

0.76

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

760

1.17

0.76

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

306

1.28

0.74

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

101

1164

0.87

0.73

1.3

7.35

7.46

mmol/l

0.14

1020

(3000285) Sodium [Moles/volume] in Blood

133

1.43

0.73

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

133

0.60

0.73

1.1

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

689

0.83

0.73

1.3

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

125

1.44

0.72

1.7

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.55

0.71

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.75

0.71

1.0

0.06

0.52

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

741

0.84

0.71

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

738

1.17

0.70

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

508

1.20

0.70

1.1

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

477

0.80

0.70

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.51

0.69

1.1

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

986

0.86

0.69

3.3

3.0

13.16

13.21

0.20

972

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

118

1.44

0.69

4.7

5.1

49.33

44.97

ug/min

0.09

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

292

1.27

0.69

1.7

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

292

1.27

0.69

1.7

2.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

178

1.35

0.68

1.3

1.2

2.17

1.65

mmol/l

0.39

109

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.64

0.68

1.3

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.59

0.68

1.9

2.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

365

1.23

0.67

1.1

95.83

94.35

0.15

279

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.63

0.66

1.3

1.2

6.87

0.99

u/ml

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.53

0.66

1.6

2.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

276

1.27

0.66

1.4

1.3

53.80

54.82

0.05

232

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

223

1.30

0.66

2.4

6.0

66.05

70.97

0.35

172

(3042631) Mycobacterium sp identified in Specimen

149

1336

1.12

0.66

2.6

2.7

—

(40768446) Kidney Pathology biopsy report

321

1.25

0.66

1.8

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

260

0.73

0.65

1.8

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

350

0.77

0.65

2.6

1.6

—

(3017569) Oxygen content in Arterial blood

467

1.20

0.65

2.4

2.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

376

1.22

0.65

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

154

1.36

0.64

1.2

1.4

—

(3025130) Human papilloma virus identified in Specimen

124

1102

1.13

0.64

1.8

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

207

1.31

0.63

1.3

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.52

0.62

1.1

1.0

0.45

0.16

u/ml

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

270

1.26

0.62

1.3

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

480

1.19

0.61

2.1

2.0

—

(3051101) Glucose [Moles/volume] in Cord blood

163

0.67

0.59

3.5

6.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

499

0.82

0.59

1.3

1.53

1.57

g/l

0.64

499

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

236

1.27

0.59

1.4

1.3

30.53

36.74

0.39

156

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

845

1.14

0.59

1.6

1.5

29.02

30.58

0.15

513

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

733

1.15

0.59

1.2

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

228

1.27

0.58

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

605

0.84

0.57

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

511

1.18

0.57

1.6

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

364

1.21

0.57

2.0

—

(3000012) Reticulocyte production index

152

1380

1.10

0.56

1.8

2.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.43

0.56

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

173

1583

1.09

0.55

1.4

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

212

1.27

0.55

1.8

2.4

7.81

7.91

mmol/l

0.03

132

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

256

2383

1.08

0.54

3.4

3.3

1.55

1.57

mg/l

0.10

233

2176

(3003434) Protein [Mass/volume] in Pleural fluid

118

1311

0.90

0.54

1.4

1.5

33.03

32.31

g/l

0.25

107

1179

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

295

2765

1.07

0.52

1.9

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.52

1.2

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

178

1.29

0.52

1.6

2.3

1.17

1.19

mmol/l

0.62

172

(21494434) Karyotype in Bone marrow

808

1.13

0.51

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.50

0.51

1.2

1.5

—

(40758358) Immune stain study

1.50

0.51

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

761

1.13

0.51

2.0

2.1

2.53

2.05

u/field

0.33

296

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

135

1.33

0.51

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

135

1.33

0.51

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

135

1.33

0.51

1.4

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

509

1.16

0.50

1.6

1.5

—

(3014891) Appearance of Pleural fluid

127

1.34

0.49

1.1

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.56

0.48

1.4

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.56

0.48

1.3

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

455

1.17

0.48

2.5

2.6

209.00

204.69

u/l

0.16

450

(3004809) Band form neutrophils/100 leukocytes in Blood

176

1625

1.08

0.48

2.5

3.4

1.17

1.54

1.16

156

1438

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.52

0.48

5.6

3.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

128

1.33

0.47

10.6

12.0

7.22

5.33

mmol/l

0.61

128

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

173

1.27

0.46

1.6

3.1

141.50

147.30

ng/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

221

0.77

0.46

4.2

7.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.37

0.44

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

208

0.77

0.43

3.1

2.5

—

(3000330) Specific gravity of Urine by Test strip

462

4825

0.96

0.43

3.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

257

1.21

0.43

1.1

1.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.40

0.42

1.0

1.1

—

4.25

—

(3042733) HLA Ab [Presence] in Serum

249

1.21

0.41

5.6

4.9

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.41

0.0

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

106

1161

0.91

0.40

1.6

1.7

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.40

0.0

1.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

10.39

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.47

0.40

1.0

1.1

557.20

255.09

nmol/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

194

0.77

0.40

3.7

7.5

—

(3009871) Measles virus Ab [Titer] in Serum

260

0.81

0.40

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

238

0.80

0.40

1.3

1.6

10.49

13.57

g/l

0.59

187

(3005082) Progesterone [Moles/volume] in Serum or Plasma

306

1.18

0.39

1.4

1.3

28.37

31.14

nmol/l

0.27

269

(46235168) Fasting glucose [Moles/volume] in Blood

1.34

0.39

4.8

3.3

8.06

7.20

mmol/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

508

4888

1.04

0.39

2.6

3.7

47.65

68.94

u/ml

0.88

477

4710

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

580

1.12

0.38

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

326

1.17

0.38

2.6

1.8

383.33

71536.59

u/ml

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.32

0.37

1.2

1.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.33

0.37

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

115

1060

1.09

0.36

2.5

1.00

1.32

g/24h

0.60

514

(3004775) Volume in Urine collected for unspecified duration

755

0.90

0.35

2.4

2.2

575.12

651.89

1.06

495

(3014148) Varicella zoster virus Ab [Titer] in Serum

107

986

1.09

0.35

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

245

2326

1.05

0.34

1.3

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.37

0.34

3.3

2.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.33

0.33

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.30

0.33

1.0

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.30

0.33

1.5

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

1.30

0.33

1.5

1.0

—

(3019174) dRVVT (LA screen)

1.35

0.32

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

1040

0.92

0.32

1.2

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.30

0.30

1.0

—

(3022475) Manganese [Moles/volume] in Blood

1.27

0.30

1.0

1.4

—

(3035880) pH of Pleural fluid

525

0.89

0.29

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

152

0.79

0.29

4.1

7.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.28

0.28

1.0

1.2

156.33

106.19

ug/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.27

0.27

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

566

1.10

0.27

1.5

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

224

1.16

0.27

3.2

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.30

0.26

2.8

5.9

—

(3022689) Creatine [Moles/volume] in Urine

267

0.86

0.25

1.3

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

188

1.17

0.25

1.1

1.3

—

(3024263) Appearance of Synovial fluid

483

1.10

0.24

1.4

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

198

1.16

0.24

1.3

1.1

—

(40768800) Prostate Pathology biopsy report

168

1763

0.95

0.24

1.2

—

(3002619) Bacteria identified in Specimen by Culture

189

1.16

0.24

1.5

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.28

0.23

1.4

1.0

—

(3024471) HLA-A [Type]

253

0.87

0.22

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

247

1.13

0.22

1.9

1.6

8.69

8.77

ug/l

0.04

247

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

381

1.10

0.22

1.9

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

381

1.10

0.22

1.9

2.0

—

(40768793) Breast Pathology biopsy report

209

2174

0.96

0.22

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

497

1.09

0.21

1.2

1.3

5.65

5.87

mmol/l

0.98

471

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

894

0.94

0.21

1.3

417.31

350.05

u/l

0.48

846

(3041184) Isoniazid [Presence] in Urine

0.00

0.20

0.0

2.1

—

(3034426) Prothrombin time (PT)

297

1.11

0.20

1.1

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.22

0.20

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

333

0.90

0.19

2.1

2.2

387.53

4608.13

e6/l

0.90

230

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

337

3463

0.97

0.19

2.8

3.5

594.30

2200.81

u/ml

1.10

281

2974

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.23

0.18

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.13

0.18

1.0

—

(3012441) Differential panel - Pleural fluid

1010

0.95

0.17

1.4

1.5

—

(3001556) Androgen free Index in Serum or Plasma

1.13

0.17

1.6

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

205

1.12

0.17

1.9

1.4

29.16

27.37

g/l

0.19

161

(3007916) DNA double strand Ab [Titer] in Serum

120

1.17

0.16

1.3

1.4

—

127.74

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

225

1.11

0.16

1.4

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

293

1.09

0.15

2.0

23954.86

16872.13

e6/l

0.15

160

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

322

1.09

0.15

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

575

1.06

0.15

6.3

6.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

150

0.87

0.14

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

197

2026

0.97

0.14

2.4

3.4

489.62

651.34

u/ml

0.22

184

1841

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

471

1.06

0.13

2.3

2.1

122.50

163.26

ug/min

0.16

118

(4212803) Bone marrow aspirate examination

1.17

0.13

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

117

0.85

0.13

1.0

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

142

1.13

0.12

1.6

—

(40765096) Chromosome analysis panel by Banding

262

0.92

0.12

1.3

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

786

1.04

0.12

1.2

1.4

2.63

4.29

ug/l

1.52

670

(3045788) Cell count panel - Pleural fluid

885

1.04

0.12

1.4

1.5

—

(3018133) Calcium [Moles/volume] in Urine

133

1.13

0.12

2.7

1.8

2.66

2.51

mmol/l

0.10

114

(3043410) Blood group antigens tested for on Red Blood Cells

251

0.92

0.12

1.1

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

387

1.06

0.10

1.9

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

309

1.07

0.10

1.6

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

144

1.11

0.10

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

447

1.05

0.10

1.6

1.8

—

(3044007) Cell count panel - Peritoneal fluid

269

0.93

0.10

2.9

1.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.11

0.09

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.11

0.09

1.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.15

0.09

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

879

0.97

0.09

1.3

1.4

5.84

6.39

mmol/l

1.05

808

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.04

0.09

1.4

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.11

0.09

2.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

233

1.07

0.09

1.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

492

0.96

0.09

2.7

41.31

39.42

0.33

287

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.82

0.08

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.81

0.08

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

117

1.11

0.08

1.2

1.6

—

(3024932) HLA-DR beta [Type]

246

0.93

0.08

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

303

1.06

0.07

1.1

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

392

1.05

0.07

35.8

26.4

119.63

109.37

ug/l

0.35

325

(3001729) Color of Synovial fluid

1.03

0.07

1.1

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.84

0.07

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.03

0.07

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

177

1.07

0.06

1.4

1.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

101

0.89

0.06

1.2

—

(40768795) Lymph node Pathology biopsy report

928

1.02

0.06

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

130

1324

0.98

0.06

1.8

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

172

0.93

0.06

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

385

1.04

0.05

1.2

4.3

91.66

1211.87

mg/l

0.77

273

(3028308) Erythrocytes [#/volume] in Pleural fluid

103

1050

0.98

0.05

1.4

1.5

89036.51

65024.66

e6/l

0.24

621

(40757373) Influenza virus identified in Isolate

171

0.94

0.05

1.8

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

199

1.06

0.04

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

101

1.09

0.04

1.5

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

114

1157

0.99

0.04

1.4

1.5

4119.57

2064.22

e6/l

0.92

835

(3000034) Microalbumin [Mass/volume] in Urine

875

0.98

0.04

2.8

3.0

16.16

47.60

mg/l

2.36

640

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

129

0.93

0.03

1.4

1.3

29.43

295.83

u/l

—

(3033799) Differential panel - Peritoneal fluid

300

0.97

0.03

2.6

2.0

—

(3026470) Cobalt [Mass/volume] in Blood

628

1.02

0.03

2.0

1.9

3.50

3.56

ug/l

0.03

571

(40768441) Liver Pathology biopsy report

681

0.98

0.02

1.4

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

281

1.03

0.02

1.2

1.3

73.05

408.91

ug/l

1.42

151

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

859

1.01

0.02

2.1

2.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

338

0.98

0.01

1.6

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

210

2089

1.01

0.01

1.3

1.4

88.99

184.64

pmol/l

6.71

204

2030

(3025577) Chromium [Mass/volume] in Blood

612

1.01

0.01

2.0

2.19

2.43

ug/l

0.26

514

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

658

0.99

0.01

1.6

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1027

10284

1.00

0.01

3.3

4.1

13.55

27.61

ug/l

1.55

817

8385

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

818

0.99

0.01

1.1

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

323

1.02

0.01

3.2

3.6

55.06

53.91

0.11

308

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

903

1.01

0.01

1.2

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

204

1.03

0.00

1.0

—

(3016750) Collection duration of Urine

534

1.01

0.00

2.3

2.1

490.45

498.24

min

0.24

388

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

117

1.03

0.00

2.3

1.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

137

1.02

0.00

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

693

1.00

0.00

1.3

14.47

13.09

u/l

0.33

634

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

296

1.01

0.00

2.4

2.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.05

0.00

1.1

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

115

0.96

0.00

6.8

8.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

155

0.97

0.00

2.1

3.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

755

0.99

0.00

1.9

1.8

3.83

4.15

mg/l

0.33

717

(3042010) Triglyceride [Moles/volume] in Pleural fluid

142

0.99

0.00

1.2

1.46

1.66

mmol/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

302

0.99

0.00

1.2

35.42

39.83

g/l

0.39

158

(3006462) Nitrate [Presence] in Urine

468

1.00

0.00

3.7

3.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

202

2022

1.00

0.00

5.6

3.6

23.47

27.78

mg/l

0.98

120

1257

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.49

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

0.00

0.0

1.1

—

71.57

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.99

0.00

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.88

-0.00

1.2

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.93

-0.00

1.4

1.2

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.2

—

36.93

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

173.33

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.95

-0.00

4.5

2.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.93

-0.00

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.91

-0.00

3.8

3.1

—

0.00

—

(3050794) Legionella sp Ab [Presence] in Serum

0.91

-0.00

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.93

-0.00

1.4

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

200

1.00

-0.00

1.1

1.8

2.70

2.26

ug/l

—

104

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

2.3

—

4.75

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_XTRAPYROTH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_XTRAPYROTH	1.297 [1.18, 1.42]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.201

During the follow-up period (1.1.1998 — 31.12.2019), 5348 out of 24658 females with G6_XTRAPYROTH died.

Males

Parameter	HR [95% CI]	p-value
G6_XTRAPYROTH	1.541 [1.4, 1.7]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.023

During the follow-up period (1.1.1998 — 31.12.2019), 5694 out of 19166 males with G6_XTRAPYROTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_XTRAPYROTH.

N-year risk	Females	Males
1	0.113%	0.318%
5	0.748%	1.726%
10	1.92%	4.587%
15	3.477%	8.658%
20	6.49%	14.437%

Relationships between endpoints

↥

Index endpoint: G6_XTRAPYROTH – Other extrapyramidal and movement disorders in other diseases

GWS hits: 9

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other extrapyramidal and movement disorders in other diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints